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INTRODUCTION
Management of infectious disease continues to be dependent on primary isola-
tion and culturing of organisms infecting biological fluids. The time consumed-
in these processes does not allow for immediate and informed treatment of the
patient. In the past several years, much attention has been directed toward
the development of bioluminescent and chemilumine scent systems as rapid
diagnostic tools. Instrumentation and procedures compatible with automation
now allow for the sensitive detection of as few as 10, 000 bacteria/ml in bio-
logical fluids. Quantitation is immediate, accurate, reproducible, and inde-
pendent of overnight culturing.
The medical applications of luminescent systems, which will be described,
are a direct outgrowth of the National Aeronautics and Space Administration
(NASA) effort to develop methods for detecting extraterrestrial life. The
firefly luciferase assay for adenosine triphosphate (ATP) was a candidate
for remote detection of microbes on other planets, such as Mars, as ATP
is found in all living organisms on Earth. An indication of the presence
of ATP on another planet would suggest the existence of extraterrestrial
life forms similar to those we know (Reference 1)..
The firefly luciferase ATP assay involves an enzymatic reaction specific
for ATP that results in the production of light (References 2, 3). The reaction
mechanism for light emission can be summarized as follows (Reference 4):
E + LH2 + ATP Mg - E • LH2 ' AMP + PP	 (1)
E LH2 • AMP + 02 —Oxyluciferin + CO2 + AMP + b y	(2)
where	 E = firefly luciferase
i
LH2 = luciferin (reduced state)
r
	ATP = adenosine triphosphate
E_ • LH2 AMP
	
	 luciferase-luciferyl-adenylate complex
(active intermediate)
oxyluciferin = luciferin (oxidized state)
PP	 pyrophosphate
AMP = adenosine - 5 1 monophosphate
	
by	light at an emission maxima 550 nm
When ATP is added to luciferase, luciferin, and magnesium ion, the light
produced is in direct vroportion to the ATP concentration. The relevance
of this assay to the field of infectious disease methodology derives from
the ability to subsequently relate concentrations of bacterial ATP to bac-
teria/ml in a biological fluid, such as urine or blood. Procedures
using the firefly luciferase ATP assay have been developed for selective
measurement of soluble ATP or mammalian cell ATP in body fluids,
detection and quantitation of bacteriuria and bacteremia, and testing of
antimicrobial susceptibilities.
Applications of this versatile assay are not limited to the medical field, but
include monitoring levels of microorganisms in drinking water, sewage
treatment plant effluent, industrial effluents, activated sludge (Reference 5),
industrial effluents, freshwater streams, ocean sites (References 6, 7),
food, beverages, pharmaceuticais, gasolines,, oils, etc.
A second bioluminescent system that offers quantitative information on bac-
terial levels in body fluids involves the specific reaction of bacterial luciferase
with flavin mononucleotide (FMN) to produce light. The overall reaction se-
quence for the in vitro reaction may be simplified as follows
FMNH2 + RCHO + 02 luciferase light + products
	 (3)
where:	 FMNH2	 reduced FMN
	
RCHO	 saturated long-chain aldehyde (C6 to
C 14)
02 = oxygen
	
luciferase	 bacterial luciferase }
(The reaction intermediates and products remain to be established definitively.)
The bacterial luciferase FMN assay is similar to the firefly luciferase ATP`
assay in that light emission is proportional to the limiting component FMN when
all others are in excess. FMN concentration can be related to bacterial
levels or used directly in the evaluation of abnormal flavin concentrations
which might then relate to metabolic disorders (Reference 8).
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C hemilumines cent methods, including luminol chemilumine scent procedures,
offer some advantages over bioluminescent enzymatic systems that must
incorporate precautions to ensure enzyme stability. In the case of the firefly
luciferase ATP assay, dependence on firefly lantern availability and the ,ical
synthesis of luciferin (LH2) add significantly to costs. Luminol, the synthetic
chemical responsible for light production in one chemilumines cent system,
is readily available in large quantities at low cost. The light produced is a
result of luminol reacting with bacterial iron porphyrins in the presence of
hydrogen perioxide (Reference 9) :
	
Luminol + H2O2 Porphyries- Excited Luminol - Products +	 (4)
or Metallic
	 by 470 nmIons
Specificity of this luminol system approaches that of the bioluminescent sys-
tems when luminol activators other than intra-bacterial porphyrins are effec-
tively eliminated. The sensitivity is comparable or better in most cases.
This chapter seeks to provide the information necessary to use luminescent
systems as analytical tools in the management of infectious disease programs.
Applications of the firefly luciferase ATP assay are the central focus, as
substantial effort has been expended in the development and clinical testing
of the various techniques employed. Instrumentation, reagents, and procedures
are described in considerable detail with emphasis on practical considerations.
The references at the end of the report may provide more background infor-
mation, discussion of the principles involved, and additional data evolved in
the course of methodology development.
INSTRUMENTATION
Any photometric instrument to be used in measuring the low light levels en-
countered in bioluminescent and chemilumines cent reactions must be able
to provide sensitive, linear, and reproducible results. Such results will be
dependent in large part on the quality of the photomultiplier tube and the abili*.v
of the instrument to null background noise and endogenous light, and to yield
a high signal-to-noise ratio. Instruments suitable for this purpose include
commercially available photometers sold by E. I. du Pont de Nemours
Company, Inc.*, Scientific Applications Inc. (SAI)T, and the American
*E. I. du Pont de Nemours Company, Inc., Instrument Products Division,
Wilmington, Dela pare 19898
TSAI Technology, Inc., 4060 Sorrento Valley Blvd., San Diego California 92121
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Instrument Company (Amino)*; a newly developed photometer to be marketed
by Vitatect Corporation**; and standard liquid scintillation counters.
Most photometers follow a basic design similar to the one schematically
diagrammed in figure 1. A high voltage supply provides power to the photo-
multiplier tube which is positioned so that light from the reaction strikes the
photocathode. The signal from the photomultiplier tube is amplified and a
readout device such as a digital display, a meter, or a rapid response recorder
assigns a numerical value. Background noise, which must be nulled before
measurement of the sample, emanates from the endogenous light of the
reactant and/or from the dark current resulting from thermal electron emissions
from the photocathode.
The light flash produced in luminescent reactions can be measured in terms
of either the peak light response or the integrated area under the light reaction
curve. In theory, integration should provide the most sensitive measurement
of light production. However, in the case of the firefly luciferase ATP assay
(and other enzymatic luminescent reactions), sensitivity is negated by blank
light levels produced by the chemical environment of the ATP sample-enzyme
mixture, and by endogenous light levels which emanate from the enzyme itself,
and which are believed to be due to the release of ATP from nonactive sites on
the luciferase molecule. In addition, ATP produced from contaminating
nucleotide phosphates by diphosphonucleotide kinases reaches a peak light
level at a much slower rate than in situ ATP; therefore, instantaneous peak
height is a more valid measurement of the original ATP in the sample in this
case. Some of these problems associated with the firefly luciferase ATP assay
that affect the accuracy and sensitivity of integrating the light signal can be
mitigated by using highly purified luciferase preparations (Reference 10),
s
CHARACTERISTICS OF COMMERCIALLY AVAILABLE PHOTOMETERS
a
Bioluminescent and chemilumines cent research at Goddard Space Flight Center
(GSFC) has involved the use of three commercially available photometers:
the Du Pont 760 Luminescence Biometer; the SAI model 2000 ATP Photometer,
and the Aminco Chem-Glow Photometer. Each instrument has been modified
to allow injection of liquid into liquid in a light-tight environment. A hollow
metal tower (11 -x 105 mm) that can house a disposable tuberculin syringe
	
i
(1 cc) has been fitted into the instrument injection port to prevent light from
*American Instrument' Company, Division of Travenol Laboratories, Inc.,
8030 Georgia Avenue, Silver Spring, Maryland 20910'
**Vitatect Corporation, P. 0. Box 31108, Temple Hills, Maryland 20031
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Figure 1. Basic Photometer Design
entering he reaction chamber via the injection syringe.  A soft rubber 	 mdia hrag	 Jdiaph agm
fits into the bottom of the tower to be pierced by the injection needle (22-gauge,
1 1/211 ). After repeated injections the diaphragm offers little resistance to the
penetrating needle and light may leak into the reaction chamber. The dia-
phragm should be replaced as needed to avoid light leakage.
I
Accuracy in measuring light responses from luminescent reactions can be af-
fected by inconsistencies in the speed of syringe injections. A protracted in-
jection results in a lower peak light response due to the instantaneous nature of
luminescent reactions, while a quick and forceful injection creates undesirable
air bubbles that interfere with light from the reaction mixture reaching the pho-
tocathode. A technician can master a deliberate, medium injection speed for
maximum and consistent light values. Several companies, including Shandon
Southern Instruments, Inc., Aminco, and the Hamilton Company, manufacture 	 s
mechanical injection devices designed to eliminate fluctuations in injection
speed and volume (Reference 11),
Each photometer can be effectively calibrated and checked for stability using
radioactive light sources with their constant light output and long half-lives.
A convenient standard consists of a radioactive material such as C14-glucose
5
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in a liquid scintillator. This is sealed into a glass cuvette (Standard CS-1 from
Johnston Laboratories in Cockeysville, Md. ). The Du Pont Biometer requires
a light standard of 10 microcuries per cuvette for calibration, although it can
also be calibrated by setting an internal lamp to an ATP standard as suggested
in the Du Pont manual. SAI and Aminco instruments can use either 10 or 1 micro-
curie light standards. Aminco provides a 1 microcurie light standard with each
meter.
Du Pont 760 Luminescence Biometer
The Du Pont Biometer shown in figure 2 is specifically designed to measure the
peak light response of lamirescent reactions. It has proven to be n successful
tool in such varied applications as microbial detection (Reference 12), water
quality assessment (Reference 13) and the detection of penicillin in milk
(Reference 14). The instrumental design provides for amplification of an analog
signal from the photomultiplier tube and subsequent charging of a "memory"
capacitor. The peak accumulates for 3 seconds before conversion into a con-
venient digital display incorporating an automatic range change over decades.
The instrument also furnishes an automatic zeroing switch to null background
noise.
Figure 2. Du Pont Biometer
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The reaction chamber, diagrammed in figure 3, is housed in a cylindrical drum
which, when rotated, exposes to the ph-`::multiplier tube the luminescent react-
ant contained in a 6- x 50-mm glass cuvette (available from Du Pont). A total
of 0.2 ml post-injection reaction mixture is visible to the photocathode for light-
response measurement. Depression of the read buttat, reveals the numerical
interpretation of the peak light signal.
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Figure 3„ Du Pont Biometer, Reaction Chamber
SAI Model 2000 Photometer
The SAI photometer shown in figure 4 measures luminescent reaction response
in either peak mode, requiring 6 seconds of assay time, or integrated mode,
requiring 60 seconds. SAI's latest model 3000 photometer offers an added
option for varying time of integration. Successful and varied applications of
7
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Figure 4. SAI Model 2000 Photometer (i, 'ormerly JR13)
these photometric instruments include the measurement of algal ATP (Reference
15), oil field bactericide parameters (Reference 16), and ATP in soil and marine
sediments (Reference 17).
In the SAI photometers, a shutter separates the photomultiplier tube from the
reaction chamber as indicated in figure 5. Opening the shutter exposes the
reaction mixture to the photocathode. A maximum volume of 2.0 ml contained
in a standard scintillation vial may be assayed using the retlectorized conical
sample holder provided by the company. An additional reflectorized conical
holder has been fabricated at Goddard to accommodate a 6 x 50 mm cuvette.
SAI also markets an automated injector kit which precludes the need to mix re-
actants in the vial before placement in the reaction chamber. An assay button
when pressed provides a maximum 6-digit readout of the peak or integrated
light response.
8
PHOTO
MULTIPLIER
TUBE
ATP PHOTOMETER
JRB)	 SYRINGE
i
LIGHT BAFFLE TOWER _,.
REMOVEABLE
	 DIAPHRAGM
LEVER	
TOP	 /
INTERCHANGABL E
CUVETTE
	
x
N^OLDER	 yJ*,'--.."Jk,CUVETTE
REFLECTOR
SURFACE
PHOTOCATHODE
	 4 ^,^,
OF PMT
SHUTTER
(VIEWED FROM BELOW)
SHUTTER
Figure 5. SAI Photometer, Reaction Chamber
Aminco Chem-Glow Photometer
The Chem-Glow Photometer shown in figure 6 registers peak light response on
a meter with a manual range selection of 4 decades. Readout for this photometer,
as well as for the Biometer and SAI models, can also be monitored by oscillo-
scope or by a strip chart recorder, such as the Hewlett Packard (lbloseley) x-y
recorder providing an x axis speed of 0.25 to 50 seconds per cm. An Aminco
integrator attachment measures total light flux for periods between 1 and 60
seconds with digital display of 3 decades. With integrator, recorder, and
automatic injector, the peak and total light response can be read simultaneously.
The Chem -Glow has been used successfully in such applications as the
determination of ATP content in germinating seeds (Reference 18), quantifi-
cation of algal ATP (Reference 19), and physiological studies of calcinosis
(Reference 20).
A rotating drum (see figure 7) houses 6- x 50-mm glass cuvettes with maximum
exposure of 0.4 ml of reaction mixture to the photocathode. Use of 12 x 35 mm
cuvette. s in a larger optional reaction head exposes a 1.7 ml sample volume.
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Figure 6. Aminco Chem-Glow Photometer and Integrator
COMPARISON OF PHOTOMETERS
The commercially available photometers discussed in this section have been
tested and compared on the basis of functional sensitivity, linearity, and re-
producibility. Tests include measured responses to a series of radioactive
light standards varying by factors of ten, to serial dilutions of purified chemical
ATP using the firefly luciferase ATP assay, and to extracted ATP from serial
dilutions of E. coli using the same assay (Reference 21).
Adjusting the photomultiplier tube gain so that a particular radioactive light
standard is set to the same percentage of the total range for each photometer,
allows full use of the range of each instrument independent of the others.
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Figure 7. Chem-Glow Photometer, Reaction Chamber
Choice of arbitrary "y" values for any particular curve permits all curves to
be shown on the same graph. Therefore, figures 8 through 12 do not indicate
absolute relationships between the photometers.
Figure 8 represents readings obtained from a series of four radioactive light
standards. Linearity and reproducibility appear to be comparable in all cases.
It is necessary, however, to use the integrator attachment with the Chem-Glow
photometer to achieve sensitivity comparable to the Du Pont and SAI model
photometers.
Figure 9 represents standard ATP curves produced by the three photometers.
Linearity and sensitivity are quite comparable. Reproducibility begins to fail
below a sensitivity level of 10 -6 micrograms of injected ATP, as indicated
by the extended Chem-Glow curve. Light responses from standard ATP diluted
in nitric acid to simulate bacterial ATP extraction are graphed in figure 10.
Figure 11 represents ATP curves at varying integration times, using the Chem-
Glow photometer and integrator attachment. These data reveal that linearity
is not dependent on integration time.
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Light responses to serial dilutions of ATP extracted from E. coli with nitric
acid are shown in figure 12. About 104 bacteria injected can be detected
reliably with all three instruments in peak and integrated modes.
VITATECT II
Vitatect<Corporation is in the process of marketing an instrument that provides
	
x
a movable filter tape for concentrating and processing the sample, a unique
feature among photometers. In the detection of microorganisms using the
firefly luciferase ATP assay, the concentration of bacteria, extraction of ATP,
and reaction with luciferase all occur on the filter tape inside the photometer.
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Comparing Three Photometers
Vitatect H, a prototype instrument shown in figure 13 and evaluated at GSFC,
consists of a reaction system incorporating the movable O.22µ filter tape and
a photometer with a ten-stage head-on photomultiplier tube operated at 2000
volts. Momentary peak light emissions register on a log decade meter and inte-
gration values ranging from 0 to 99 seconds, with a selected 0- to 99-second
delay, concurrently appear in digital display over a range of 7 decades
(Reference 22).
The reaction system schematically diagrammed in figure 14 incorporates three
separate injection ports: one for the initial application of the sample to the
filter tape; one for optional treatment of materials held by the filter with
washing solutions or extracting agents; and one for addition of the light-producing
reagent. An indexed knob moves the (extracted) sample-impregnated-area
of the filter into reaction position above the photocathode where a transparent 	 y
cellophane tape forms a backing for the filter tape and protects the surface of
'	 the photomultiplier tube. The light-producing reagent is injected in a volume	 a
I	barely sufficient to wet the impregnated area and penetrate the back of the
filter tape. Light emission is then registered in terms of peak and integrated
values (Reference 22).
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Comparing the Three Photometers
An evaluation of the performance characteristics of the Vitatect II included
tests similar to those used in comparative studies of the other commercially
available photometers. The radioactive light standards when exposed to the
photocathode confirm linearity within and between range settings as well as
reproducibility at each combination. The results of serial dilutions of ATP
applied to the filter tape and reacted with firefly luciferase above the photo-
cathode demonstrate a sensitivity of 10 -g micrograms of injected ATP which
is similar to the sensitivity of other photometers. A concentration curve meas-
ured by the firefly luciferase ATP assay confirms overall linearity, repro-
ducibility, and sensitivity provided by this instrument. Table 1 lists bacteria
per ml as determined by an initial Coulter count, light response to each
dilution minus a reagent blank reading, and coefficients of variation. The
results taken at 30-second integration counts appear to be linear from 7 x 108
to about 104 bacteria per ml.
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LIQUID SCINTILLATION COUNTERS
In addition to these photometers, liquid scintillation counters designed to measure
radioactivity, and spectrophotometers (Reference 23) have been used successfully
to measure low level light reactions. In luminescent reactions the enzyme or
chemilumine scent compound is the light producer instead of the liquid scintillator.
The resultant light flash is measured in photons per second. Scintillation counters
utilize two photomultiplier tubes and coincidence circuitry to reduce false counts
given by extraneous sources. Coincidence circuitry should not be used with lu-
minescent light emissions since only single photon events occur, and a loss in
signal will result in the case of a low concentration of unknown sample (ATP,
for example). To use a scintillation counter effectively with luminescent reac-
tions, simply disconnect one of the photomultiplier tubes prior to assay or de-
activate the coincidence circuits (Reference 24). These photomultiplier tubes
are of particularly high quality, and are often cooled to further reduce dark
current.
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The additional sensitivity achieved with the use of high quality photomultiplier
tubes in liquid scintillation counters may actually prove to be a disadvantage
when measuring bioluminescent and chemilumine scent reactions. Inherent light
levels due to the luciferase enzyme or to the chemi luminescent reactant, and
blank light levels produced by all reagents in the sample except the factor being
measured, may register high readings. Blank sample readings, including in-
herent light of the reactant, should be subtracted from sample readings for the
unknown factor in order to reflect true sample values. High blank levels will
also limit the available range for sample measurement above the blank value.
Another disadvantage is that the configuration of the liquid scintillation instru-
ment does not lend itself to reactions requiring addition of one liquid to another
in a light-tight environment. Unless the instrument has been mechanically
modified, sample and reactant must be premixed outside of the instrument and
then inserted into the scintillation counter chamber. Because luminescent re-
actions are instantaneous, seconds lost in mixing and positioning the reactants
may result in a measurement that misses the peak light response.
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Table 1
Bacterial Concentration Curve Showing Net Light Units
and Coefficient of Variation (%)
Bacteria/Filter/ml Net Light Units CV
7.2 x 100 3.43 1.22
7.2 x 101 2.25 7.7
7.2 x 102 3.68 1.89
7.2 x 103 6.00 8.16
7.2 x 104 3.42 x 101 4.99
7.2 x 10 5 4.00 x 102 3.13
7.2 x 106 2.95 x 10 3 4.38
7.2 x 107 3.25 x 104 10.2
7.2 x 108 3.48 x 10' 1.44
FIREFLY LUCIFERASE ADENOSINE TRIPHOSPHATE (ATP) ASSAY
3
REAGENTS
All reagents are prepared in sterile distilled deionized water, from chemicalsg	 p	 .	 ^	 .	 a
of the highest purity available. It is advisable to use disposable plasticware or
glassware that has been acid cleaned (soaked in 1.0 N HCI for 30 minutes), and
thoroughly rinsed in distilled H 2O, to remove residual ATP. Avoid the use of
potassium salts as these are more inhibitory to luciferase than sodium salts;
therefore, pH adjustments should be made with NaOH and HCI. Reagent solu-
tions must be stored at 10C or lower (refrigerated) to inhibit bacterial growth.
Adenosine Triphosphate (ATP)
Determination of the light response from a known quantity of ATP in a defined
reagent environment allows the conversion of light units to micrograms (µ g)
of ATP for a sample assayed in the same luciferase preparation under the same
defined reagent conditions.
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Adenosine 5' Triphosphate: Equine Muscle Disodium Salt, crystalline form
molecular weight (MW) 614.2
Sigma Chemical Company
Each preweighed vial contains 30 mg ATP which is 99 percent pure and
contains 3.5 H2p per mole (the amount of H2O of hydration is variable).
Store at -20°C
Preparation of Stock-
1000 p g ATP/ml
MW pure ATP = 507.2
MW Sigma disodium salt = 614.2
.milligrams of pure ATP in 30 mg Sigma ATP at 99% purity=
507.2 x 30 mg x 0.99 = 24.53 mg 	 -
614.2
24.53 mg ATP + 24.53 ml H2O ----1000 µg ATP/ml
• Add 24.53 ml H2O to contents of one vial Sigma ATP and mix well:
Rinse vial with ATP solution to collect any remaining ATP. Mix final
solution well.
''	
a
• Dispense in 1000 µg (1 ml) aliquots and store at -200C.
Preparation of ATP Dilutions-
• Dilute stock serially 1:10 to desired concentration using diluent appro-
priate for application P 20, saline, HNO3, • and so on).
j
• ATP is unstable and cannot be stored at room temperature or refriger-
ated without a steady decline in activity. It is therefore necessary to
prepare fresh standard ATP from frozen stock for use with each assay.,
Alternatively, a 1:10 dilution of stock in M SO4 (1 x 10 -2
 M) and eth-
yleonediamine tetraacetic acid (EDTA) (1 x g 0-3 M) can be stored,at
R '	 25 C for an 8-hour period without significant decay of ATP and used
as a stock for further dilution throughout the day. Be sure to dilute
'	 Mg+2 /EDTA-treated ATP before use as a standard assay because this
concentration of Mg+2 inhibits the luciferase response by about 30 percent.
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Apyrase
Soluble ATP, which may contaminate a sample to be assayed for bacterial ATP
can be removed by the addition of apyrase, an ATP hydrolyzing enzyme.
The pH for optimum apyrase activity is 6.0. The lowest pH for activity is 3.0.
The apyrase must be inactivated before extracting the bacterial ATP to be
assayed. This is done with the extractant, nitric acid, by lowering the pH to
below 3.0. Apyrase can be reactivated if the pH is again raised, so care must
be taken with the extracted samples to keep the pH below 3. 0, until injection
into the luciferase. Since Ca+2 is required as a cofactor at an acting concen-
tration of 5 x 10- 3 M, apyrase is extracted in the appropriate molarity of
CaC12.
Apyrase is very stable and extremely active. It contains varyir.g amounts of
ATPase, ADPase, and AMPase activity. Because there may b^ phosphorylating
enzymes associated with the luciferase enzyme preparation, the presence of
ADP and AMP can interfere with quantitation of the amount of ATP when using
the luciferase reaction. Each lot of apyrase should be assayed for its ability
to produce a low blank with a high concentration of ATP after a constant time.
The concentration of the new lot should be adjusted to give a constant activity;
for example, removal of 100 µg ATP in 15 minutes to two times the blank level.
When using concentration procedures, different lots of apyrase may result in
varying amounts of particulates that interfere with extraction and mixing by
clogging a filter or settling in a pellet in the centrifuge tube. In such cases,
10 to 100 mg/ml of apyrase are extracted in CaC12 and centrifuged (10, 000 rpm
for 5 minutes) or filtered. Apyrase may then be lyophilized for storage and
reconstituted to the desired activity when needed.
Apyrase: 5' ATPase-2.5 units per mg, 5' ADPase-0.46 units per mg, 5' AMPase-
0.,03 units per mg.
Potato purified-grade 1
Sigma Chemical Company_
	
x
Store dry below 0°C
2, 000 units per vial based on 5' -ATPase activity
20
Calcium Chloride (CaC12)
Within the concentration range of apyrase used (acting concentration I to 10 mg/
ml), calcium is required as a cofactor at 5 x 10 -3
 M. Apyrase is rehydrated in
the appropriate molarity of CaCl2 (or CaCl2 - 0. 6 percent TX) to maintain an
acting concentration of approximately 5 x 10- 3 M Ca+2.
A stock solution of 3 M CaC12 is stored at -20"C.
Calcium Chloride (Anhydrous)
MW 110.99
Analytical reagent
Mallinckrodt Laboratory Chemicals
Store at room temperature
Preparation of 100 ml of U. 03 M CaC12, 0. 6-percent Triton X-100 (TX-100):
(1) Combine I ml stock 3 M CaC1 2
 and 10 ml 6-percent Triton X-100.
(2) Add H2O to produce 100 ml and mix well.
I
Cleland's Reagent
Cleland's reagent is a sulfhydryl protecting compound. Since luciferase con-
tains sulfhydryl groups at its active sites, a solution of 1 x 10-3 M Cleland's
in the rehydrating Tris (hydroxymethyl)'aminomethane (IRIS) buffer will maintain
maximum luciferase activity for 8 hours with refrigeration, and will minimize
activity decay during an assay period.
Dithioerythritol or Dithiothreitol
MW 154.3
Sigma Chemical Company
Store desiccated at 0 to 50C
21.
Eth_ylenediamine TetraaceticAcid (EDTA)
The chelating agent EDTA may be used at a concentration of 1 x 10- 3 M to
stabilize both standard ATP and luciferase for 24 hours and to limit inhibition
of the reaction by metallic ions.
Ethlenediamine Tetraacetic Acid: Disodium Salt
MW 336.2
Sigma Chemical Company
Store at room temperature
Luciferin-Luciferase
Dessicated firefly lanterns maybe extracted in buffer to yield a crude luciferin-
luciferase preparation. The enzyme luciferase is apparently a protein of MW
50, 000 which commonly occurs in an aggregrate (dimer) form. There is evi-
dence that luciferase is actually a heterogeneous group of proteins with slightly
different substrate binding properties (Reference 25). Each protein unit has
several free sulfhydryl groups, of which two are essential for luciferin binding.
The cofactor magnesium is required at 1 x 10- 2 M for formation of the activated
enzyme-substrate (luciferin MW 280.33) complex.
Crude extracts of firefly lanterns are available from Calbiochem, Antonik, Inc.,
Sigma Chemical Company, and Worthington Biochemical Corporation at a cost of
less than $0.10 per assay. Procedures for further purification require the ad-
dition of synthetic luciferin (approximately $3.00 per mg) which increases the
cost of the assay but significantly improves sensitivity (approximately 100 fold).
Boehringer Mannheim and E. I. Du Pont offer purified enzyme preparations.
The Du Pont purified luciferin-luciferase has been utilized for our procedures
development. Each reagent kit consists of 20 vials of lyophilized enzyme-
substrate, 1 vial morpholinopropane sulfonic acid (MOPS) buffer tablets, and 	
w
reaction cuvettes (6 x 50 mm) at a cost of about $300 (as of 1976). The enzyme
k	 is stored at -2ft. Du Pont recommends rehydration of one vial in 3.0 ml of
the supplied MOPS buffer. To obtain maximum sensitivity, we suggest rehydrat-
ing in 1.5 ml TRIS-Mg+2 buffer, which yields 300 assays per reagent kit (0.1 ml
E	 enzyme-substrate per assay).
I	
^
The salt required for solubility of the globulin luciferase is supplied by the
k ehydration buffer IRIS, as is the cofactor magnesium. The addition of
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r1 x 10-3
 M Cleland's reagent (in TRIS buffer) promotes enzyme stability by
protecting the sulfhydryl groups. Rehydrated enzyme, stored in the dark at
100C, will remain stable (negligible activity loss) for 4 hours. This period is
increased to 8 hours in Cleland's reagent, and with the addition of 1 x 10- 3
 M
EDTA, it is stable for 24 hours. EDTA is not necessary for short-term storage
and need not be used unless pooled enzyme is prepared for use over an entire
workday, or metallic contaminants are expected in the sample.
	
ai
After rehydration, the luciferase mixture emits light without the addition of any
ATP. This inherent light may be due to small amounts of ATP in the enzyme
	 j
mixture that are not removed during purification. Incubation of rehydrated
enzyme at room temperature, for at least 45 min. prior to assay, will reduce
the level of inherent light.
An alternative method for obtaining highly purified luciferase (at reduced cost)
involves preparation from dessicated firefly tails as follows:
Preparation of Acetone Powder-
0 Grind firefly lanterns (Sigma Chemical Company, Antonik, Worthington,,
or Calbiochem—$20 per gram) and a small quantity of sand with mortar
and pestle, keeping the mixture cold with liquid nitrogen or an acetone-
dry ice mixture. Grind to a fine powder.
• Extract with cold acetone (40C) for 10 minutes to remove lipids (at least
100 ml per 5 grams).
• Filter (Buchner) and wash with cold acetone. Dry completely and store
at -20 C.
Preparation of Crude Extract of Luciferase-Luciferin—
• Add 10 ml cold 0.05 M TRIS, pH 7. 75, with 1 x 10` 3 M Cleland's
reagent per gram acetone, powder. Mix gently at 10 0 C for 30 minutes.
i
• Centrifuge at 10, 000 relative centrifugal force x gravity (RCF x G) for
10 minutes. Collect supernate and discard precipitate.
Purification of Luciferase—
• At room temperature bring to 30 percent,(NH4)2 SO4, and discard
-	 precipitate; bring to 70 percent (NH4)2 SO4, and collect precipitate.
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ft.
• Wash luciferase (70 percent precipitate) in 70 percent (NH 4)2 SO4
pH 7.75.
• Dissolve washed pellet in TRIS buffer: 0.05 M, pH 7. 75, 1 x 10- 3 M
Cleland's reagent, 1 x 10- 2
 M MgSO4 (minimum volume 2.5 ml/g
acetone powder). Centrifuge to clarify. Apply enzyme to Sephadex
G-200 column and elute with the same TRIS buffer. Assay fractions by
mixing small portion 1:1 with luciferin in TRIS buffer.
• Pool fractions with high activity and low inherent light. (One gram of
acetone powder should produce about 20 ml of enzyme with activity equal
to the Du Pont product.) Dilute pool (with same TRIS buffer) to desired
activity level. Add 0.1 mg luciferin per 1 ml diluted fraction pool.
Aliquot and lyophilize enzyme. Store dessicated a^ 200C.
• Rehydrate in H2O (for 0.05 M TRIS, pH 7.75) or 0.20 M TRIS, pH
8.2 (for 0.25 M TRIS, pH 8.20).
Magnesium Sulfate (MgSO4)
Magnesium is a cofactor required in the luciferase reaction at a concentration
of 10-2 M. This is added to TRIS buffer to reach a final concentration of 0.01
M MgSO4 (1.0 ml stock 1 M MgSO4 plus 99 ml TRIS buffer). MgSO4 in the same
concentration may be used to stabilize standard ATP.
Magnesium Sulfate (Anhydrous) -Certified ACS
MW 120.37
Fisher Scientific Company
Store at room temperature.
A stock solution of 1 M MgSO4 is stored at -20C.
Malate Buffer
Contaminating ATP in a sample to be assayed for bacterial ATP may be bound
to surfaces and large molecules, such as membrane fragments and proteins,
that protect-it from hydrolysis by apyrase. Release of bound ATP occurs if
the pH of the specimen is dropped to approximately 4..25, where the binding
-	 of ATP by salt linkages is depressed and apyrase remains marginally active.
r
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Malic acid buffers effectively in this pH range with a pK of 3.4.
Malic Acid
MW 134.1
Sigma Chemical Company
Store at room temperature.
Nitric Acid (HNO3)
Nitric acid inactivates apyrase and ruptures the bacterial cells, releasing bac-
terial ATP. The optimal nitric acid concentration is the lowest necessary for
complete ATP extraction. For 10 bacterial urinary pathogens tested, 0.1
N HNO3
 was found to be the optimal extracting concentration, added directly to
the pellet or filter for extraction. If the bacteria are not concentrated in a
negligible volume, a stronger nitric acid concentration must be added to account
for acid dilution by sample volume and to achieve the final extracting concentra-
tion of 0.1 N. The pH of the nitric-treated sample should be at or below 1.2.
Nitric Acid: Reagent ACS
Fisher Scientific Company
16 Normal, 71 percent by weight
Store at room temperature
Preparation of Stock
-a
(1) 1.5 N: 9.37 ml 16 N HNO3 per 100/ml
(2) 1.0 N: 6.25 ml 16 N HNO 3 per 100/ml
3
(3) Stock solution should be stored at 10°C or lower.
Rhozyme-41
Rhozyme-41 is a mixture of proteases from Aspergillis orizae. The enzyme is
active over pH 6 through 9, with the optimum for degradation of urine glyco-
proteins and mammalian cell membranes being about pH 8.
J
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Rhozyme-41 Concentrate
Rohm and Haas Company
Store at 10 C or lower
Preparation
(1) Extract Rhozyme concentrate in H2O (8 g powder concentrate in 92 ml
H2O) overnight at 100C.
(2) Centrifuge at 12, 000 RCF x G, and filter supernate (0a2µ).
O(3) Store supernate at 10 C, and use within 48 hours.
Sodium Sulfate (Na2SO4)
Sodium sulfate has recently been substituted for H2O as the diluent in the nitric
acid extraction procedures. It has been determined that Na2SO4 lowers the blank
reading by approximately 70 percent with a concurrent 50 percent loss in luciferase
activity, thereby effecting a net increase in sensitivity. The Na 2SO4 is used to
adjust the ionic strength of the injected sample to.equal or exceed the ionic
strength of the luciferase preparation. The sample pH after Na2SO 4 addition
should be 1.8 to 2.1.
Sodium Sulfate: Certified ACS (Anhydrous)
MW 142.04
Fisher Scientific Company
1
Store at room temperature
TRIS Buffer
The lyophilized luciferase powder is rehydrated in TRIS buffer, containing mag-
nesium, a cofactor in the reaction. One vial of powder is rehydrated in 1. 5 ml
TRIS-Mg buffer. The pH and concentration of the TRIS are critical. For opti-
mum light response, the final pH after injection of the sample should be 7.75
f0. 1. If the sample contains HNO 3, the concentration and pH of the TRIS must
be adjusted to maintain the reaction pH optimum. Use of the lowest concentra-
tion and pH of TRIS that will maintain pH 7.75 will minimize luciferase activity
loss. TRIS is also used to buffer samples requiring rhozyme to approximately
PH 8.. 0.
26
Trizma Base (iris [hydroxymethyl] aminomethane: Reagent Grade)
MW 121.1
Sigma Chemical Company
Store at room temperature
Preparation of StoclZ (100 ml) 2 M TRIS
(1) Add 24.2 g of Trizma Base to 80 ml of H2O, Mix occasionally to
dissolve; do not heat.
(2) Bring solution to final volume of 100 ml.
(3) Filter through 0.22 p membrane,
(4) Store at -200C.
j
Preparation of Rehydrating Buffer
(1) 0.05 M TRIS: 2.5 ml 2 M stock/100 ml
0.25 M TRIS: 12.5 ml 2 M stock/100 ml
2 If TRIS is to be used to reconstitute luciferase 0 01 M M SOO	 ^	 ^	 MgSO4 and
1 x 10-3 M Cleland's reagent are required. For every 100 ml of
TRIS to be made, decrease volume of H2O by 1.0 ml and add 1, 0 ml
1 M stock MgSO4 and 15.43 mg Cleland's reagent. (EDTA may also
be added at 1 x 10- 3 M for increased luciferase stability, but since
rehydrated enzyme is seldom stored for more than a few hours, EDTA
is not routinely placed in the rehydrating buffer.
(3) The pH of the solution is adjusted before bringing it up to final volume:
pH 7.75 for 0.05M TRIS and pH 8.20 for 0.25M TRIS. To allow for
the addition of pH' reagents (HCl and NaOH), the solution should be
brought to about 8C percent of final volume before pH adjustment. It
should then be brought to full volume and the pH rechecked,
Triton X-100
Frequently, a specimen to be analyzed for bacteria contains contaminating non-
bacterial cells such as mammlian cells: red blood cells, white blood cells, or
epithelial cells. To obtain true bacterial values, these other sources of ATP
must be removed prior to bacteria rupture. The nonbacterial ATP is released
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jby Triton X-100 (TX), a nonionic detergent, making the ATP accessible to hy-
drolysis by potato apyrase. Triton X-100 is added at 0.001 percent to all re-
agents used in filtration procedures to facilitate rapid sample and reagent flow.
Triton X-100 (Octyl Phenoxy Polyethoxyethanol)
Sigma Chemical Company
j (Triton is a trademark of the Rohm and Haas Company)
Store at room temperature
Preparation of 100 ml of 6-Percent TX-100 Stock Solution:
(1) Fill pipette with 6.0 ml of TX, do not overfill (use a pipette filler).
Wipe off outside of pipette.
(2) Rinse pipette in 94 ml of warm H2O until all TX is dissolved. Swirl
gently to mix.
(3) Heat TX solution just to boiling. It will become cloudy, but will clarify
on cooling.
3
Preparation of 100.0 ml of 10-Percent TX-100 Stock Solution:
(1) Heat 90.0 ml of H2O as above.
i
(2) Add 10.0 ml of TX-100 as above.
-CAUTION-
Care should be taken not to swallow any TX-100, as ingestion
of TX in rats has been shown to cause subcapsular cysts on the
ovaries. If TX should come in contact with skin, wash imme-
diately with volumes of tap water.
Typical Listing of Reagent Supplies
E. I. Du Pont de Nemours and Company, Inc.
Instrument Products Division
Wilmington, Delaware 19898
(302) 774-1000
28
iFisher Scientific Company
711 Forbes Avenue
Pittsburgh, Pennsylvania 15219
(412) 781-3400
Mallinckrodt Laboratory Chemicals
223 West Side Avenue
P. O. Box 384
Jersey City, New Jersey 07303
(201) 432-2500
Rohm and Haas Company
Independence Mall West
Philadephia, Pennsylvania 19105
(215) 592-3143
Sigma Chemical Company
P. O. Box 14508
St. Louis, Missouri 63178
(314) 771-5765
ALTERNATIVE EXTRACTION PROCEDURES
In addition to HNO 3 , several extractants were tested in conjunction with our
procedures development including ionizing organic solvents (90-percent dimethyl
sulfoxide (DMSO), 10-percent formamide), nonionizing organic solvents (90-
percent acetone, butanol, chloroform, ethanol, methanol, methylene chloride),
boiling TRIS buffer, and other inorganic acids (H2SO4, H3PO4, and perchloric).
Of these extractants, only a,few proved efficient in the extraction of bacterial
ATP: 90-percent acetone, boiling TRIS, 90-percent methylene chloride, 90-
percent DMSO, H2SO4, perchloric acid, and HNO3.
When acids are used as extracting agents, the molarity of TRIS used for luci-
ferase rehydration must be high enough to maintain optimal reaction pH. Non-
ionizing organic solvents (removed in extraction procedure by heating) and
boiling TRIS do not alter the reaction pH on injection. This allows the use of
low molarity TRIS at pH 7.75 which increases enzyme activity. Acid extraction,
however, is instantaneous and has the added advantage of inactivating ATPases	 a
which may be released on bacterial ATP extraction or added for removal of
soluble ATP.
The injection of DMSO (at about 70-percent concentration) results in a 90-percent
loss in luciferase activity. Dilution of the DMSO extracted sample before assay
reduces this loss. Potential sensitivity losses are negated by low blank levels
(compared to acid extractants).
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-CAUTION-
It should be remembered that methylene chloride and DMSO
are hazardous compounds. Do not mouth pipette or allow
slain contact.
Inorganic Acids: HNO 3 H2SO4, PCA (perchloric acid)
Extraction Procedure—
• Add 0.2 ml of 0.1 N acid to bacterial (sample) pellet. Wait 5 minutes.
Dilute with 0.2 ml of 0.15 M Na2SO4, Vortex.	
N
Or add 0. 1 ml of 1. 5 N acid to 0. 5 ml sample fluid. Vortex. Wait 5
minutes. Dilute with 4.4 ml of 0.085 M Na 2SO4. Vortex.
• Assay: luciferase prepared in 0.25 M TRIS, pH 8. 2, 1 x 10 -2
 M
MgSO41 1 x 10-3 M Cleland's reagent.
Nonionizing Organic Solvents: Acetone, Methylene Chloride
Extraction Procedure—
• Add 5 ml of 90-percent organic solvent to bacterial pellet or 4.5 ml
of 100-percent organic solvent to 0.5 ml of sample fluid. Vortex.
Heat at 90°C for 40 minutes to evaporate solvent. Add 0.4 ml of
0.085 M Na2SO4. Vortex.
i
• Assay: luciferase prepared in 0.05 M TRIS, pH 7. 75, 1 x 10_ 2 M	
bMgSO4, 1 x 10-3 M Cleland's Reagents.
Boiling Tris
Procedure-
• Add 5 ml of boiling 0.02 M TRIS, pH 7. 75, to pellet or 4, 5 ml of boiling
0.02 M TRIS, pH 7.75, to 0.5 ml of sample fluid. Mix. Heat 5 minutes
at 100 C. Cool in ice bath (or dilute with TRIS).
• Assay: luciferase prepared in 0.05 M TRIS, pH 7. 75, 1 x 10-2 M
-3 -M Cleland's reagnet.1VIgSO4, 1 x 10 
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DMSO
Filter Procedure using 90-percent DMSO-
0 Filter sample on 0.22 or 0.45 JA Gelman Acropore membrane.
• Wash with 10 ml saline.
• Add 2 ml of 90-percent DMSO. Wait 3 minutes. Collect extract.
• Add additional 2 ml of 90-percent DMSO. Wait 3 minutes. Collect
extract.
0 Add 1 ml of H2O. Collect extract.
• Assay: luciferase prepared in 0.05 M TRIS, pH 7. 75, 1 x 10-2 M
MgSO41 1 X 10-3 M Cleland's reagent.
MEASUREMENT OF SOLUBLE ATP IN BODY FLUIDS
Measurable quantities of soluble ATP pervade most body fluids in addition to
the ATP that may be extracted or freed from bacteria. Cellular debris or
membrane fragments of mammalian cells found in urine, for example, are also
sources of soluble ATP. Because ATP is an important energy-rich compound
required in the proper functioning of all cells, fluctuations in soluble ATP levels
may be indicative of bodily changes occurring in response to a particular envi-
ronment, malfunction, or disease. Such fluctuations can be monitored by selec-
tively measuring free ATP using the firefly luciferase assay. The amount of
light produced from the reaction between the body fluid and the luciferase is
proportional to the amount of ATP present in solution.
Reagents
Apyrase
0.03' M CaC12
1.5 N HNO3
Sterile deionized water
Luciferase rehydrated in 0.25 M IRIS, 0.01 M MgSO 49 10
-3
 M Cleland's
reagent, pH 8.2.
Standard ATP
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Procedure
Removal of all ATP for Blank Measurement—Filter urine through a 0.45 N Milli
-pore cellulose filter to remove all particulate sources of ATP. To a 0.5-m1
sample of prefiltered urine, add 0.1 ml of 10 mg apyrase per ml 0.03 M CaCl2.
Vortex, and wait 15 minutes for enzyme to hydrolyze all soluble ATP. Add 0. 1
ml 1.5 N HNO3, and dilute with 4.3 ml sterile, deionized water.
Assay by injecting 0.1 ml of the sample into 0.1 ml of luciferase rehydrated in
0.25 M TRIS, 0.01 M MgSO 40 10-3 M Cleland's reagent, pH 8.2.- Record light
units.
Selective Measurement of Soluble ATP—To a second 0.5-m1 sample of prefiltered
urine add 0.1 ml 1.5 N HNO 3 and 0.1 ml of 10-mg apyrase per ml 0.03 M CaC12.
In the presence of the nitric acid, the apyrase is inactive and serves only to sim-
ulate the chemical environment of the blank. Dilute with 4.3 ml H2O and assay
by injecting 0.1 ml of the sample into 0.1 ml luciferase rehydrated in 0.25 M
TRIS, 0.01 M MgSO41 10-3 M Cleland's reagent, pH 8.2. Record light units.
Discussion
The difference between the light units generated by the sample and the blank
light units represents the light signal due to soluble ATP. For greater accuracy
in the measurement of small amounts of soluble ATP, the blank and sample light
unit values must emanate from a common chemical environment. Nitric acid
is added to the blank after apyrase has hydrolyzed all free ATP in order to create
the same background solution as in the sample which contains nitric-acid-
inactivated apyrase.
To translate light units into micrograms of ATP per ml, an ATP standard must
be processed in the same manner as the blank, adding a known concentration of
ATP diluted in the nitric acid. The signal due to soluble ATP will then be di-
rectly proportional to the ATP standard signal times the known concentration of
ATP in the standard.
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Example of Values
The soluble ATP detection procedure demonstrates a range of sensitivity from
10- 5 micrograms to 10 -1 micrograms ATP per ml sample. Soluble ATP values
found in random clinical urine samples are given in the following list*:
Specimen #	 gg Soluble ATP/ml
1	 1.67 x 10-2
2	 2.53 x 10-1
3	 4. 62 x 10-3
4	 4.80x10-2
5	 7.48 x 10-2
6	 5.29 x 10-2
Conditions for Use
The usefulness of soluble ATP measurements in predicting or evaluating the
course of an infection or metabolic disease remains to be determined by hospital
studies. Dynamic changes in ATP levels may prove meaningful in following
nutritional programs, diagnostic treatments, or the recovery of health.
MEASUREMENTS OF MAMMALIAN CELL ATP IN BODY FLUIDS
Flexibility in the use of reagents that hydrolyze ATP and rupture cells allows
for selective measurement not only of soluble or bacterial ATP, but also of
ATP associated with mammalian cells such as leukocytes, erythrocytes, plate-
lets, epithelial, muscle, and germinal cells as they occur in body fluids.
Measurements of erythrocyte ATP levels have been used as a means of
monitoring the freshness of blood for transfusion.** Decreases in ATP levels of
stored blood appear to be associated with loss of freshness due to age and unfav-
orable storage conditions.
1
*Jaffee, B. D., Hahnemann Medical College and Hospital, Department of Micro-
biology, 230 N, Broad St., Philadelphia, Pennsylvania 19102, unpublished data
**Nakasako, Harber General Hospital, Department of Microbiology, 1124 W.
Carson St., Torrance, California 90502, personal communication
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The procedure for measuring ATP in blood cells involves initial hydrolysis of
soluble ATP by an ATPase, inactivation of that ATPase, rupture of blood cells,
and reaction of the freed ATP with luciferase. Since blood cells contain about
one thousand times as much ATP as bacterial cells, the presence of any bac-
terial ATP in the sample will be insignificant, unless the sample has been con-
centrated for bacteria. Following is a list of concentrations of ATP per cell
type common to biological fluids.
Cell Type
	 u g ATP
Average Bacterium	 2. 5 x 10-10
Platelet	 3.2 x 10-9
White Blood Cell	 2.1 x 10-7
Red Blood Cell	 1.2 x 10-7
Total ATP per ml Whole Blood	 6 x 102
QUANTITATION OF BACTERIA IN BODY FLUIDS BY MEASURING ATP
Introduction
Although the ATP content of a bacterium may vary somewhat through a growth
cycle (References 26 and 27) and with species (Reference 28) an average of
2.5 x 10-10
 pg ATP per organism has proved useful in relating bacterial ATP
levels and bacterial cell numbers. In order to quantitate bacteria in clinical
urine or blood samples, however,, any soluble ATP or ATP from nonbacterial
cells such as erythrocytes and leukocytes must be removed first (References
	 a
29, 30 and 31). The combined use of reagents that selectively rupture mam-
malian cells and hydrolyze free ATP, prepares the sample for subsequent de-
activation of hydrolysis, lysis of bacteria and measurement of bacterial ATP
by the firefly luciferase assay.
l
Several procedures for quantitating bacteria in pure cultures, in clinical urine
and in blood samples have been developed (Reference 21). Pure cultures or
samples containing high levels of bacterial ATP and low levels of competing
	
j
sources of ATP may be assayed without concentration of the sample. For
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greater sensitivity and more efficient removal of interfering ATP, the organisms
in the sample may be concentrated by either centrifugation or filtration, both of
which permit washing of the bacteria. In detecting the presence of bacterial
ATP in blood cultures, most of the mammalian cells are removed physically
rather than chemically by selective centrifugation. Once the bacteria are de-
tected and quantitated, rapid antibiograms can be obtained by subjecting an in-
oculum of the concentrated organisms to antibiotics and measuring differences
in ATP levels over a 2.5 hour Incubation period.
Controls and Calculations
In order to calculate micrograms of ATP per ml from recorded light twit read-
ings for the sample being assayed, blank and ATP-standard values must be ob-
tained. The blank sample contains the background fluid, such as sterile urine,
sterile broth or sterile saline, and is treated with all reagents in the same man-
ner as the test sample. The purpose of the blank is to determine the amount of
light which is produced by the chemical environment of the sample and which is
not a result of bacteria. Generally, the blank level is low enough to be insignif-
icant; however, when the sample light unit reading is very low, it becomes im-
portant to subtract the blank value.
The basic conversion of sample light units to micrograms of ATP per ml in-
volves a comparison of sample light units with light units obtained from a known
amoutn of ATP standard solution. If the proportion of the original sample as-
sayed and that of the ATP standard solution assayed are the same, then the
concentration of ATP in the unknown sample is directly proportional to the ratio
of the light units from the sample to the light units from the standard ATP times
the concentration of ATP in the standard solution. This relationship may be
expressed as
Sample L. U. (Minus Blank)	 Concentration	 Concentration of
	
x of ATP in the	 ATP in the sample (5)
Standard L. U. (Minus Blank) 	 Standard
where L. U. light units`
i
	
	 If the proportions of sample and standard assayed are not the same, a simple
methematical correction for volume differences is necessary.
An ATP standard can be prepared in two ways. If a small volume (0.05 ml) of
an ATP dilution is added to the sample tube, the control is referred to as a
recovery standard. The sample light units obtained before the addition of ATP
must be subtracted to obtain a light-.unit reading due to the added ATP alone,
as opposed to the ATP of the organism. The volumes must be noted in order to
correct proportions for the above calculations.
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Rather than adding ATP to a sample tube from which aliquots have been removed
for injection, the preferred method involves preparation of a duplicate blank or
sample to which a solution of ATP, diluted in the required volume of extractant,
is added. In this type of standard, referred to as a processed standard, the
added ATP is subjected to the same extracting environment as the organism
ATP. In addition, the sample and standard volumes are identical, making cal-
culations straightforward.
Nonconcentrated Procedure for Measuring Bacteria' ATP
Reagents-
Apyrase
0.03 M CaC12 (0.6 percent TX-100)
. 5 N HNO3
Sterile, deionized H2O or 0.085 M Na2SO4
Luciferase rehydrated in 0.25 M IRIS,
0.01 M MgSO4, 10-3 M Cleland's, pH 8.2
Procedure-
0 Removal of Interfering ATP—To a 0.5-m1 sample in a sterile, poly-
propylene test tube, add_0.1 ml of 10 mg apyrase per ml 0.03 M CaCl2
(with 0.6 percent TX-100 if contaminating mammalian cells are
[ present). Vortex and wait 15 minutes for apyrase to hydrolyze free ATP.
• Release of Bacterial ATP —Add 0.1 ml of 1.5 N HNO 3 to deactivate the
apyrase and rupture the bacteria. Vortex and wait 5 minutes for com-
plete extraction. Dilute extracted ATP with 4.3 ml of sterile, deionized
H2O or 0.085 M Na2SO4. Vortex.
• Assay Bacterial ATP-Inject b.1 ml of processed sample into 0.1 ml
of luciferase, rehydrated in 0.25 M IRIS, 0.01 M MgSO4 , 10-3 M
Cleland's reagent, pH 8.2. ' Record light units.
€	
Conditions for Use Since this procedure does not allow for concentration of
bacterial ATP, it is recommended for the analysis of pure cultures or of those
samples which contain high levels of bacterial ATP and low levels of such com-
peting sources of ATP as blood cells or tissue cells. By forfeiting the sensitivity
that can be achieved with concentration, the procedure remains rapid and simple;
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a sample of minimal volume can be assayed in 30 minutes with few manipulations.
Sensitivity—This nonconcentrated procedure actually effects a ten-fold dilution of
the original sample. Nevertheless, the lower limit of sensitivity approaches
1 x 10 5 bacteria per ml.	 i
Concentration Procedures
For greater sensitivity in the detection of low numbers of bacteria in biological
fluids, the organisms can be concentrated by centrifugation or filtration. The
concentration procedures that follow also allow soluble factors that might other-
wise inhibit the luciferase-ATP reaction to be physically removed in the super-
nate or filtrate, and the bacteria to be washed free of contaminating sources of
ATP. The concentration procedures can effectively prevent mammalian cells
(at levels as high as 3 x 10 6 white blood cells per ml urine sample, or a 10-
percent blood contamination) from interfering with the final bacteria ATP measure-
ment (Reference 32).
Centrifugation Procedure for Urine—
• Reagents-
6-percent TX-100
Apyrase
0 03 M CaC12
0.9-percent saline
0.5 M malic acid, pH 4.25
a
0.1 N HNO3
Sterile, deionized H2O or 0.15 M Na2SO4
Luciferase rehydrated in 0.25 M IRIS, 0.01 M MgSO4 9 10-3 M Cleland's
reagent, pH 8.2.
x
• Procedure
(1) Removal of Interfering ATP-To a 10-m1 sample in a sterile
12-m1 polypropylene centrifuge tube add 0.2 ml of 6-percent
TX-100 to selectively lyre contaminating nonbacterial cells
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Tsuch as erythrocytes and leukocytes. Centrifuge at 10, 400 x G
for 15 minutes at 20°C to concentrate bacteria in a pellet; decant
supernate to remove soluble inhibitors; invert tube and drain 5
minutes.
Add 1.0 ml of 10-mg apyrase per ml of 0.03 M CaC1 2 to hy-
drolyze remaining soluble ATP. Vortex well. Add 5.0 ml of
0.9-percent saline as a wash, vortex, and wait 15 minutes to
allow apyrase to work.
x
Add 1.0 ml of 0.5 M malic acid, pH 4.25. At this pH, the
membrane-bound nonbacterial ATP is released and then hy-
drolyzed by the apyrase. Centrifuge at 10, 400 RCF x G for
15 minutes at 2ft, decant supernate to remove apyrase and
malic acid, invert tube and drain for 5 minutes.
(2) Release of Bacterial ATP-To the pellet add 0.2 ml of 0. 1 N
HNO3, vortex well and wait 5 minutes. The low pH of the nitric
acid deactivates any remaining apyrases and extracts ATP from
the bacterial cells. Add 0.2 ml of sterile, deionized water or
0.15 M Na2SO4 to dilute the nitric acid, and limit its effect on
the extracted ATP and the luciferase-ATP reaction.
(3) ATP Assay—Inject 0.1-m1 of final processed sample into 0.1 ml
of luciferase rehydrated in 0.25 M IRIS, 0.01 M MgSO4, 10-3
M Cleland's reagent, pH 8.2. Record light units,
y
• Controls and Calculations—To determine the micrograms of ATP per
ml and the number of bacteria per ml of urine sample from the recorded
9light unit reading requires blank and ATP standard values. A quick
"processed" standard can be obtained by assaying 0.1 ml of a mixture
of 0.2 ml of 0. 1 N HNO 3 and 0.2 ml of a known ATP dilution in water.
A more accurate standard for a clinical urine sample, which reflects
the total chemical environment of which the bacterial ATP is exposed,
requires treating a 10-m1 sample of sterile urine with all of the re-
agents enumerated in the foregoing procedure, adding a given concen-
tration of ATP with the extractant. A reagent blank is obtained in the
same fashion, omitting the addition of ATP.
• Sensitivity- The centrifugation procedure effects a 25-fold concentration
of the bacteria from a 10-m1 sample of urine. Because interfering
particles and nonbacterial cells are also concentrated in the pellet, <.
malic acid wash is included to allow apyrase hydrolysis of membrane
bound ATP as well as hydrolysis of soluble ATP which is released by
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the selective rupturing agent TX-100. Concentration of the bacteria and
more effective removal of nonbacterial ATP result in a detection sensi-
tivity as low as 1 x 104
 bacteria per ml of the original 10 ml sample.
• Practical Applications—Bacterial counts as determined by the luciferase
assay of bacterial ATP in urine, using the centrifugation procedure,
have been correlated with standard hospital plate counts. The ATP
assay successfully separated uninfected urine samples from those with
medically significant bacterial infections of 3 x 10 4 bacteria per ml or
greater with a false negative rate of only 1.3 percent (Reference 32).
Such correlation indicates that the procedure could be a useful, accurate,
and rapid tool for screening clinical urine samples. At this false nega-
tive level, however, 25 percent of the urines are reported as false
positives. The causes of this disagreement with routine plate count
(a method which itself has a certain percentage of error) are under
investigation.,
Although this procedure involves a number of manipulations, many of
the steps lend themselves to automation. The filtration procedure yet to
be described holds the most promise for development of a completely
automated rapid bacterial detection system for clinical urine samples.
Either concentration, procedure, centrifugation or filtration, can be
integrated with a rapid antibiotic susceptibility test that is based on
measurements of bacterial ATP before and after incubation of the or-
ganisms in the presence of antibiotics. The initial inoculum of bacteria
required for the antibiotic test can be prepared using the quantitative
information provided by the detection assay.
The processing time of the centrifugation procedure can be shortened
to less than one hour by eliminating one centrifugation step and the use
	 7
of malic acid. Because this shortened procedure is not guaranteed to
remove bound ATP from nonbacterial sources in the sample, it is use-
ful for analysis of pure bacterial cultures in known media rather than
clinical urine or blood samples which contain other sources of non-
bacterial ATP. Practical applications include pure culture work for
evaluating new antibiotics and quality control studies of a standard
bacterial strain. The procedure is as follow:
(1) Removal of Interfering ATP—To a 5.0 -mi sample of the bacterial
culture in a 12-m1 centrifuge tube add 1. 0 ml of 10-mg apyrase
per ml of 0.03 M CaC12 (0.6 percent TX if mammalian cells
are present). Vortex and allow 15 minutes for hydrolysis of sol-
uble ATP by the apyrase. Centrifuge at 10,400 RCF x G at 20'C
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for 15 minutes, discard supernate and invert tube to drain
for 5 minutes.
(2) Release of Bacterial ATP—Add 0.2 ml of 0.1 N HNO3 to the
pellet, vortex well, and wait 5 minutes for extraction of ATP.
Dilute with 0.2 ml sterile, deionized H2O or 0.15 M Na2SO4.
(3) ATP Assay—Assay by injecting 0.1 ml of sample into 0. 1 ml
of luciferase rehydrated in 0.25 M TRIS, 0.01 M MgSO4, 10-3
M Cleland's reagent, pH 8.2. Include an assay of a processed
blank and ATP standard for calculations.
Centrifugation Procedure for Blood—Standard laboratory methods for the detec-
tion of bacteremia depend on growth, with subsequent gross and microscopic
examination of blood culture media, which requires an incubation period of at
least 18 to 24 hours to produce a visibly ''positive" result. The presence of mul-
tiplying bacteria can be detected chemically by measuring increases in the ATP
content of a blood culture sample. Depending on the species of organism and
the initial concentration of bacteria in the blood sample, the presence of bacteria
in blood can be detected by the firefly luciferase ATP assay after an incubation
period of only 5 to 12 hours (Reference 33). Although many factors contribute
to mortality from blood infections, the development of techniques that provide
earlier detection and treatment of bacteremia might serve to reduce the overall
fatality rate which is presently 20 to 75 percent (References 34 and 35).
0 Reagents—
Dextrose Phosphate Blood Culture Media (Scott Laboratories, Cat. No.
3013-2331)
6.0 percent Triton X-100
Apyrase in 0.03 M CaCl2
0.9 percent NaCl
0.5 M Malic acid (pH 3. 75)
0.1 N HNO3
Sterile, deionized water
Luciferase rehydrated in 0.25 M TRIS, 0.01 M MgSO4, 10- 3 M Cleland's
reagent, pH 8.2:
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• Procedure—
Standard Preparation and Incubation of Blood Culture Sample—Using
sterile technique, withdraw 5.0 ml of blood from patient, using a sy-
ringe containing 100 units of heparin. Transfer blood by syringe into
a Dextrose Phosphate Blood Culture bottle containing 90 ml of broth,
mix well, and incubate at 37 C.
Measurement of Bacterial ATP at t 1
 (a time interval for growth, usually
5 hours after inoculation)-The physical removal of erythrocytes and
leukocytes is accomplished as follows:
Shake culture bottle to ensure even dispersal of contents before remov-
ing portion for processing. Aspirate 12 ml of fluid through a sterile
needle into a 20-m1, sterile, plastic syringe (modified by cutting off
all but 4 cm of the plunger). With a hemostat, pull plunger until it is
flush with the end of syringe. Occlude the needle-mount of the syringe
with a plastic cap or parafilm. Place syringe in centrifuge head, needle-
mount up, and secure with cotton packing. Return culture bottle to in-
cubator for continued growth. Centrifuge the withdrawn sample at 160
RCF x G for 5 minutes at 20°C to settle most of the cellular elements
of the blood into a pellet. Bacteria are not precipitated at this speed,
and most will remain in the supernate. Attach a sterile needle, bent
at a 90 angle, to the syringe mount, and carefully transfer 10 ml of the
supernatant fluid to a'17 x 100-mm polypropylene tube without disturbing
the pellet.
Removal of nonbacterial ATP is accomplished as follows;
Add 0.2 ml of 6.0 percent Triton X-100 to the 10-m1 sample to lyse any
remaining nonbacterial cells. Concentrate bacteria by centrifuging at
10,400 RCF x G for 15 minutes at20 0 C. _ Discard supernate and invert
tube to drain for 5 minutes. To the pellet add 1.0 ml of 10-mg apyrase
per ml 0.03 M CaC12 and 5.0 ml of 0.9 percent NaCl. Vortex and allow
15 minutes for hydrolysis of soluble ATP. Add 1.0 ml of 0.5 M malic
acid, pH 3.75, to free any membrane-bound ATP for hydrolysis by the
still-active apyrase. Reconcentrate bacteria by centrifuging at 10, 400
RCF x G for 15 minutes at 2ft. Discard inhibitory soluble factors
with the supernate and invert tube to drain for 5 minutes.
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The release of bacterial ATP is accomplished as follows:
To the pellet add 0.2 ml of 0.1 N HNO3 in order to deactivate any re-
maining apyrase and to lyse bacteria. Vortex and wait 5 minutes for
complete extraction of the bacterial ATP. Dilute with 0.2 ml sterile,
deionized H2O and vortex again.
Assay ATP by injecting 0.1 ml of the final processed sample into 0.1 ml
of luciferase rehydrated in 0.25 M TRIS, 0.01 M MgSO4, 10- 3 M Cleland's
reagent, pH 8.2. Record light units.
Measurement of Bacterial ATP at t 2
 (a time interval for growth, usually
8 hours after inoculation). Remove, process and assay second portion
from the blood culture bottle as described above. An increase in light
units from tl
 to t2 indicates the presence of multiplying bacteria and,
therefore, the detection of bacteremia.
Controls—To ensure sterility of the system, incubate, process, and
assay a sample of sterile blood or broth as a blank. If quantitation of
the infecting bacteria present after t2 is desired, include a processed
standard, adding a known amount of ATP at the point where bacterial
ATP otherwise would be released. Use the blank, sample, and ATP
standard values for calculating bacteria per ml. (See "Controls and
Calculations" section.)
Practical Considerations —Although this procedure involves meticulous
	 a
techniques, many of the steps lend themselves to automation, and with
experience it may be possible to simplify some of the procedures.
Recent experiments indicate that filtration may be a promising alter-
uative to centrifugation as a means of concentrating and washing the
bacteria from blood in preparation for an ATP assay.
The biggest potential source of error in using this procedure to detect
bacteremia is maintaining the sterility of the system. Five or more
hours of incubation under optimal growth conditions might give any
contaminating bacteria ample opportunity to multiply and cause a false
indication of the presence of ba.cter^nAa,, Contaminating bacteria in-
troduced during withdrawal of the ti sample might also have enough
growth time to falsely elevate the t2 sample value. To ensure sterility,
the blood sample is removed from the culture bottle with a sterile needle
and syringe. In no case, in studies by Schrock (Reference 93) has
control sample revealed any bacterial contamination due to manipula .	°a
tions, even after incubation for 10 days and periodic subcultures on agar.
42
t	 ^
After careful withdrawal from the blood culture bottle and low-speed
centrifugation to allow separation of the bacteria from most of the man-
malian blood cells, the sample is assayed for bacterial ATP by the same
concentration procedure previously described for urine samples. With
semiquantitation of the bacteria present in the blood culture medium,
an inoculum of about 10 6 organisms per ml of trypticase-soy broth can
be developed for subsequent antibiotic susceptibility testing, using ATP
assays as described for urine samples in the section, "Integrated Procedure
for Detection and Antibiotic Susceptibilities of Bacteria Infecting Clinical
Urine Sar4ples. "
• Example of Values—Detection of bacteremia by the firefly luciferase
ATP assay has been tested using healthy blood samples inoculated with
a known concentration of bacteria per ml. An example of values ob-
tained using various inoculum sizes of an E. coli strain American Type
Culture Collection (ATCC #25922) is given in Table 2.
Table 2
Values Obtained from Various Inoculum Sizes
3
j
iThe low control values indicate that nonbacterial sources of ATP such
as erythrocytes and leukocytes have been effectively removed by the
.	 slow centrifugation step and the use of Triton X-100 detergent. After
5 hours of incubation, a significant difference is noted between the
control and all three inoculated samples, indicating bacterial growth.
Since light unit readings on the Du Pont Biometer in the range of
1 x 10 5 to 1 x 10 6 are often within blank range (depending on particular
reagent and luciferase lots), it is recommended that the culture be al-
lowed to incubate at least 8 hours (12 hours for gram-positive orga-
nisms) in order to see an unquestionable change in ATP levels as
demonstrated by the example above. Negative cultures should be re-
sampled at intervals up to 12 hours to preclude the possibility of a
slow-responding organism.
Original Inoculum t1 Light Units
(5 hours)
t2 Light Units
(8 hours)
0 bacteria per ml (control) 0. 91 x 105 0. 53 x 105
5 bacteria per ml 4.46 x 10 5 6.32 ,x 107
25 bacteria per ml 4.76 x 10 5 9.69 x 107
50 bacteria per ml 1. 70 x 10 6 2. 50 x 108
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• Sensitivity—In preliminary studies of 5 gram-negative and 5 gram-
positive organisms, the presence of multiplying gram-negative orga-
nisms from an initial inoculum of about 50 colony-forming units per ml
was readily detected within 6 hours. Lower inocula of 1 to 7 colony-
forming units per ml could usually be detected by 8 hours. Although
gram-positive strains exhibited slower growth or production of ATP,
positive results were obtained after 12 hours. False-positive readings,
where ATP analysis indicated bacteremia and agar plating resulted in
no growth, occurred in only 6 percent of instances. In no case was
any growth observed in the control samples (Reference 36). 	 .
• Conditions for Use—The successful detection of bacterial growth in
blood cultures by ATP analysis has been established using blood samples
which have been drawn from healthy volunteers and inoculated with a
known number of bacteria. The technique has not been tested exten-
sively on blood samples from patients with symptoms of bacteremia.
Continued study using clinical as opposed to laboratory cultures is re-
quired before the method can be recommended for hospital use.
Filtration Procedure for Urine-The length of time needed for each processing
step requiring concentration or washing of the sample can be reduced by filtra-
tion. As a result, more steps can be included to resolve the bacterial ATP
signal from interfering biological and chemical background— soluble or membrane-
bound nonbacterial ATP, and luciferase-inhibitory insoluble components of the
sample, such as urine crystals (salts), cell casts, and blood-cell fragments.
Particulates and macro-molecular elements that cannot be selectively washed
away prior to bacterial extraction will be retained in the filter matrix rather
than collected in the extract to be assayed. Filtration procedures may be adapted
for concentration incompletely automated systems.
Unfortunately, while all samples are readily centrifuged, not all fluids of bio-
logic origin lend themselves to rapid filtration in the volumes required for de-
tection of low-level bacterial contamination by the ATP assay. When a specimen
contains a large number of particulates (such as urine crystals), high mammalian
cell levels (such white blood cells in infected urine); or mucoid material, special
treatments are required to facilitate sample concentration and subsequent pro-
cessing (Reference 37). Varying the temperature or pH of a specimen prior to
	
r
filtration may alter the solubility of components and enhance filtration, while
changing the pH after sample concentration (as a wash step) may remove other- 	 j
wise insoluble inhibitory compounds. Enzymatic degradation of selected sample
fractions (protein complexes, mucopolysaccharides, and lipids) may minimize
filter clogging and remove or inactivate inhibitory components. Proper mem-
brane selection may be critical with more complex fluid specimens. In some
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Icases, two filters must be combined for optimum filtration-one prefilter (a
cellulose ester membrane which tolerates more debris without clogging but also
retains more fluid in its matrix), and one bacteriologic filter (a polycarbonate
membrane which clogs easily but has minimal fluid retention).
When processing individual samples, any filtration apparatus allowing both fil-
trate disposal and collection of extracted sample under pressure or vacuum
will suffice. In dealing with most samples, however, it is advantageous to employ
a vacuum device designed for multiple sample processing with minimal manip-
ulation, such as the Millipore Sampling Manifold. This unit consists of a top
plate with 12 sample ports, a lower filter support plate, and a reservoir base
with removable tray for the collection of filtrate in standard test tubes; The
unit accommodates about 15 ml of sample per port but provides only about 2. 5
square cm of filter surface (18-mm diameter), a limited filtration area which
increases the difficulty of concentrating complex fluids.
Two basic filtration procedures have been developed—a simple procedure for
fluids requiring no pretreatment, and a complex procedure designed to deal with
infected urines which might contain, for example, 5 percent whole human blood
and approximately 10 8 bacteria, thereby representing a considerable challenge
to the filtration system. Assay sensitivity varies with the procedure used.
When low levels of mammalian cells are present, a range of 700 to 5000 bacteria
per ml can be detected, depending on the urinary pathogens involved. In 5-percent
bloody urine, using the complex filtration procedure, 5000 organisms per ml of
a 10-m1 sample are routinely detected. The sample is concentrated 12.5 or 20-
fold, depending on the procedure used.
• Simple Filtration Procedure-This procedure is suitable for enumera-
tion of bacteria in a sample containing low levels of mammalian cell
contamination, where filtration difficulties are not anticipated. When
the fluid can not readily be filtered (due to high membrane, particulate,
or mucoid content), the complex filtration procedure should be utilized.
In either case, a reagent blank and ATP standard should be included to
relate sample light units to micrograms of ATP per ml or number of
bacteria per ml.
Reagents:
6 percent Triton X-100 (TX)
10'mg/ml Apyrase in 0.03 M CaCl2
0.1 N HNO3 (in 0.001 percent TX)
E
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0. 15 M Na2SO4 (in 0. 00 1 percent TX)
0. 9 percent saline (with 0.001 percent TX)
1.0 M Malic acid, pH 4.25
(preffitration of reagents is advisable)
Procedure—The removal of soluble ATP is accomplished as follows:
To a 10-m1 sample in a test tube, add 0.2 ml of 6 percent TX and
1.0 ml of 10 mg/ml apyrase in CaC12, vortex, and wait 15 minutes
for lysis of mammalian cells by TX and hydrolysis of soluble ATP
by apyrase.
The removal of membrane-bound ATP is accomplished as follows;
This optional step is required only for detection of low bacterial 	 a
levels in the presence of mammalian cells. Add 1.0 ml of malic
acid buffer to lower the pH and release bound ATP. Vortex and
wait 5 minutes for further hydrolysis by apyrase. 1
The sample is concentrated as follows;
Filter sample through 0.22 µ membrane and wash with 10 ml of saline.
Filter to dryness to prevent dilution of extractant.
i3
Extraction is accomplished as follows;
Apply 0.25 ml (this volume suitable for up to a 25-mm diameter
filter) of 0.1 N HNO3 to filter surface to inactivate ATPases, lyse
bacterial cells, and free bacterial ATP. Wait 5 minutes for com-
plete extraction, and dilute by adding 0.25 ml Na2 SO4 to filter.
Collect extract by filtration.
Assay by injecting 0.1 ml of vortexed extract into 0.1 ml of lucif
ferase rehydrated in 0.25 M'TRIS, pH 8. 2, l x 10 -2 M MgSO4, and
1- x 10-3 M Cleland's reagent. Record light units,
• Complex Filtration Procedure-This procedure is designed to minimize
mucoid and particulate clogging of the filter and remove high levels of
nonbacterial ATP. It is particularly adapted for the elimination of
physical and chemical interferences associated with mammalian tissue
{	 specimen contamination (that is, infected urines),
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Reagents;
6 percent Triton X-100 (TX)
10 mg/ml Apyrase in 0.03 M CaC12 (with 0.001 percent TX)
8 percent Rhozyme-41
1.5 M, TRIS pH 8.3
1.0 M Malic acid pH 4.0 (in 0.001 percent TX)
0.15 M Na2SO4 (in 0.001 percent TX)
0.1 N HNO3 (in 0.001 percent TX)
(prefiltration of reagents in advisable)
Procedure—Pretreatment of sample to minimize filter dogging is
accomplished as follows:
To a 10-m1 sample in test tube add 0.2 ml of 6-percent TX, 1.0 ml
of 1.5 M TRIS, and 1.0 ml of 8-percent rhozyme-41. Vortex and
wait 5 minutes for lysis of mammalian cells and degradation of
proteins (glycoproteins, blood membranes, histones, etc.) in the
buffered sample.
Concentration of sample is accomplished as follows:
Filter the pretreated sample on the Millipore Sampling Manifold
using an 8 µ cellulose ester prefilter membrane overlaying a 0.4 µ
bacteriologic polycarbonate membrane.
The release and hydrolysis of residual nonbacterial ATP is ac-
complished as follows;
Wash the filter with a minimum of 10 ml of malate buffer to lower
pH and release bound ATP. Apply 1.0 ml of 10 mg/m1 Apyrase in
0.03 M CaC12 and wait 15 minutes for hydrolysis of ATP. Remove
apyrase by filtration. Wash filter with 10 ml of Na2SO4 to prevent
buffering of the extractant by residual malic acid and apyrase.
Filter to dryness.
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Extraction is accomplished as follows:
Apply 0.4 ml 0.1 N HNO 3 to filter, wait 5 minutes for inactivation
of ATPases and release of bacterial ATP. Dilute the extract by
adding 0.4 ml of Na2SO4. Collect extract by filtration.
Assay by injecting 0.1 ml of vortexed extract into 0.1 ml of lucif-
erase rehydrated is 0.25 M TRIS, pH 8. 2, 1 x 10- 2 M MgSO4 , and
1 x 10- 3 M Cleland's reagent. 'Record light units.
Filtration Procedure for Whole Blood— It is possible to filter 5 ml of whole blood
on the 18-mm diameter Millipore Sampling Manifold filter surface, using the
double membrane system (8.0 N and 0.4µ) previously described. The blood must
be pretreated for lysis and membrane digestion as follows:
To 5 ml of whole blood, add 1.0 ml of 10 percent TX, 2.0 ml 1. 5 M TRIS, pH
8. 3, and 2.0 ml 8 percent Rhozyme-41. Vortex, wait 5 minutes, and filter.
Ten ml of whole blood is readily filtered on one 47-^m diameter, O.45µ filter
by doubling the volumes listed above. The concentration of TX required to lyse
whole blood is apparently 1-percent (acting concentration), while only 0.1
percent is necessary to lyse 10-percent blood. TX at these high concentrations
may affect the viability of organisms extracted from blood, therefore, modifi-
cation of this filtration procedure is advisable (that is, dilution to allow use of
less TX or use of another blood cell lysing agent).
The 5-percent blood-dextrose-phosphate broth described in the section "Cen-
trifugation Procedure for Blood" can be filtered using the Millipore Sampling
Manifold. Pretreatment of the blood culture (TX-Rhozyme-buffer) allows con-
centration of at least 20 ml, enabling bacterial enumeration and antibiotic sus-
ceptibility testing following the filtration procedures previously outlined,
INTEGRATED PROCEDURE FOR DETECTION AND ANTIBIOTIC SUSCEPTI-
BILITIES OF BACTERIA INFECTING CLINICAL URINE SAMPLES
The present laboratory techniques for microbial sensitivity testing, namely,
agar diffusion (Bauer-Kirby), broth dilution, and agar dilution, require overnight
incubation after primary isolation of the infecting organism. Accurate suscep-
tibility data are available to the physician a minimum of 48 hours after the spec-
imen is received in the laboratory. ' This delay often results in the initiation of
empirical and/or broad-spectrum antimicrobial therapy in urgent clinical sit-
- uations. The availability of a rapid bacterial susceptibility test would allow
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prompt selection of the most effective agent and would avoid inclusion of inap-
propriate, unnecessary, or toxic agents in the initial therapeutic regimen. The
procedure: described below, using the firefly luciferase ATP assay, detects and
quantitates bacteria present in the specimen and provides accurate, reproducible
antibiograms in approximately 4 hours (References 38, 39, and 40).
Reagents
Trypticase Soy Broth
Apyrase
0.03 M CaC12 - 0.18 percent TX-100
0, 9 percent Saline
0.25 M Malic acid
0.1 N HNO3
Sterile deionized H2O
Luciferase in 0.25 M IRIS, 0.01 M MgSO4 , 10-3 M Cleland's reagent,
pH 8.2
Antibiotic solutions (see following section)
0.03 M CaC12 - 0.6 percent TX-100
1. 5 N HNO3
Antibiotics
The antimicrobial agents that have been tested extensively for use with the ATP
assay are listed below with the appropriate final concentration to be used for
results comparable to Bauer-Kirby test (Reference 40). Concentrations were
determined empirically by measuring the effect of the mean inhibitory concen-
tration (MIC) breakpoints generally quoted for the agar diffusion method on a
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panel of prototype organisms. 	 The concentrations below fall somewhere between
these MIC breakpoints.
Antibiotic m /ml
Sodium penicillin 8
Sodium ampicillin 8
Sodium nafcillin
i
0.6
Disodium carbenicillin 128	 -
Sodium Cephalothin 16
Tetracycline hydrochloride 6
Chloramphenicol 12.5
Clindamycin phosphate 2
Erythromycin 4
Gentamicin sulfate 6
Sodium colistimethate 8
Kanamycint 15
Streptomycin 10
Nitrofurantoin 50
Most of the listed antibiotic powders are water soluble and prepared by addition
of an appropriate volume of sterile, deionized water. 	 Erythromycin and chlo-
ramphenicol are initially dissolved in about 2 ml of 95 percent ethanol, then
further diluted with water. 	 Nitrofurantoin is dissolved in Trypticase Soy Broth
after heating and requires separate A O and A2
.
5 controls that include an equi-
valent volume of broth instead of water. 	 Rapid sensitivity testing to sulfonamides 	 i
and to nalidixic acid appears impossible by the ATP assay method because con-
sistently false resistant indices result,
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Procedure for a Urine Sample Tested Against 12 Antibiotics
Preparation of Concentrated Test Portions—Centrifuge a 35-m1 clinical urine
sample at 10, 400 RCF x G for 15 minutes at 4 C. Discard supernate and re-
constitute pellet with 1.75 ml of Trypticase Soy Broth to achieve a 20-fold con-
centration of the original sample. Vortex well.
Transfer by pipette 0.5 ml of concentrated sample (representing 10 ml original
sample) to a 17 x,, f00-mm polypropylene tube for subsequent detection assay.
Store the remaining 1.25 ml (representing 25 ml of original sample) at 4°C to
be used later for antibiotic susceptibility tests. At this temperature, no change
in the bacterial concentration. should occur.
Detection Assay-
• Removal of Interfering ATP —To a 0.5 ml sample add 1.0 ml of 10 mg
apyrase per ml 0.03 M CaC12 - 0.18 percent 'TX-100 and vortex. Add
4.5 ml of 0.9-percent saline as a wash, vortex again, and allow apyrase
to hydrolyze soluble ATP for 15 minutes. Add 1.0 ml of 0.25 M malic
acid, vortex, and centrifuge at 10,400 RC  x G for 15 minutes at 4°C.
	 3
The apyrase continues to work during centrifugation on membrane-
bound ATP released by the malic acid. Discard supernate and drain
for 5 minutes in the inverted position.
• Release of Bacterial ATP—To the pellet add 0.2 ml of 0.1 N HNO3,
vortex and wait 5 minutes for extraction of ATP. Dilute with 0.2 ml
of sterile deionized water and vortex.
a
• ATP Assay—Inject 0.1 ml of sample into 0.1 ml of luciferase rehy-
drated in 0.25 M TRIS, 0.01 M MgSO 4, 10-3 M Cleland's reagent,
pH 8.2. Record light units and calculate bacteria per ml using blank
and ATP standard values. If a medically significant concentration of
bacteria exists, proceed with antibiotic testing.
Antibiotic Susceptibility Test
• Preparation and Incubation of Test Portions—Retrieve 1.25 ml of con-
centrated sample from refrigeration and dilute further with Trypticase
Soy Broth to achieve a concentration of about 10 6 bacteria per ml. Pre-
incubate sample for 30 minutes at 370C to allow organisms to reach log
growth phase.
Aliquot two 0.45-m1 portions to serve as growth controls before and
after a 2.5-hour incubation period. These controls are referred to
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as AO and A2. 5 . Aliquot one 0.45-m1 portion for each antibiotic to be
tested. These samples are referred to as B 1, B2 , B3 , etc. Add 0.05
ml of antibiotic solution (10 times the final desired concentration) to
each of these test protions and vortex. To the controls, AO and A2, 5,
add 0.05 ml of sterile, deionized water to simulate antibiotic test
portions. Incubate each test portion and the A2. 5 control at 37 0C for
2.5 hours.
• Extraction of Bacterial ATP in the AO Control —Add 0.1 ml of apyrase
(10 mg/ml 0.03 M CaC12
 - 0.6 percent TX) to hydrolyze soluble ATP.
Vortex and wait 15 minutes. Add 0.1 ml of 1.5 N HNO 3, which simul-
taneously deactivates the apyrase and releases bacterial ATP. Vortex
and wait 5 minutes. Dilute with 4.3 ml of sterile, deionized water, and
vortex. The sample may be stored at room temperature for later assay
with the A2 , 5 control and all antibiotic test portions.
• Extraction of Bacterial ATP in Incubated Samples—At the end of the
2.5-hour incubation period, remove all samples from the incubator
and to each tube add 0. l ml of apyrase (10 mg/ml 0.03 M CaC12 - 0. 6
percent TX). Vortex and wait 15 minutes for hydrolysis of soluble
ATP. Add 0.1 ml of 1. 5 N HNO3 for apyrase deactivation and ATP
extraction. Vortex and wait 15 minutes. Dilute with 4.3 ml sterile,
deionized water.
• ATP Assays-Assay all samples (A O , A2 , 5, B 1 , B 2 , B3 , etc.) by inject-
ing 0. 1 ml of the final processed sample into 0. 1 ml of luciferase rehy-
drated in 0.25 M TRIS, 0.01 M MgSO4 , 10-3 M Cleland's reagent,
pH 8.2. Record light units.
Practical Considerations
Blanks and standards are not absolutely required for the antibiotic susceptibility
test since the final index of inhibition is determined not by an absolute calculation
of micrograms of ATP per ml, or number of bacteria per ml, but rather by an
examination of relative differences between tight signals before and after incu-
bation with the antibiotic. If the infecting bacteria reconstituted in broth after
centrifugation are resistant to a particular antibiotic, growth will occur during
the incubation period. The increase in ATP that occurs with growth will be re-
flected in a significant difference between light units recorded for the A 0
 control
and the B sample. If the bacteria are sensitive, the increase in light units will
be negligible, or even negative. Uninhibited growth is represented by the A2.5
control. The ratio of growth in the presence of antibiotic to growth in the
antibiotic-free control provides a direct measurement of the drug effect.
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iSince the ATP susceptibility test relies on an increase in bacterial ATP over
time, any nonbacterial sources that might falsely elevate the A O
 determination
would elevate the A2. 5 by the same increment. This constant contribution
becomes mathematically insignificant in the final ratio calculation. For this
reason, the increased specificity for bacterial ATP afforded by the use of malic
acid and a second centrifugation step in the original detection procedure can be
sacrificed in the antibiotic test to achieve greater simplicity and rapidity.
The original detection value for bacteria per ml of urine sample provides the
basis for dilution of the stored portion to achieve a working inoculum of 106
organisms per ml for the antibiotic tests. Although the standard Bauer-Kirby
Antibiotic Disc Susceptibility Method requires a standard inoculum size, the
ATP method requires only a range of 106 to 10 7 bacteria per ml. Beyond these
range limits, accuracy of ATP results does decrease slightly as compared to
Bauer-Kirby results.	 1
7i
A laboratory experienced with the ATP antibiotic susceptibility test could de-
termine a dilution schedule directly from the detection light signal, bypassing
the need to process a blank and ATP standard for calculations. Light signals
are dependent, however, on the luciferase lot and daily conditions in the lab;
therefore, inclusion of an ATP standard for quality control is recommended.
It is possible that growth of some bacterial strains may be inhibited by exposure
to TX. To avoid this problem, the detergent required in the detection assay is
added after the initial centrifugation step has taken place and after an aliquot
for later growth in antibiotic testing has been removed. a
The procedure outlined in this section represents an integration of detection and i
antibiotic susceptibility testing, designed to limit requirements for clinical
sample volume, reagent volumes, length of time, and manipulations. The pro-
cedures may be performed separately, of course, without sacrificing accuracy
or sensitivity, particularly if large numbers of urine samples are to be screened
for significant bacterial infections before antibiotic testing is considered.
Calculations
The ATP index of inhibition for a given antibiotic is determined according to
_
ATP INDEX = Bt 
AO	
whereAt - A0
Bt = sample light units for organisms incubated with antibiotic
At control light units for organisms incubated without antibiotic
7
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it = time of incubation period
AO = control light units for organisms without antibiotic at time zero.
An ATP index :50.05 indicates sensitivity (S) to the antibiotic and index >0.05
indicates resistance (R).
Example of Values
Antibiotic susceptibility testing on a clinical urine sample with greater than
10 5
 E. coli per ml by plate count resulted in the values indicated in Table 4.
Table 3
Examples of Antibiotic Susceptibility Test Values
Sample Light Units ATP Index Interpretation
AO	 Control 9.14 x 105
A2. 5	 Control 3.61 x 10 7 - -
Bpenicillin 3.59 x 107 +.99 R
Bampicillin 1.58 x 10 5 -.02 S
Bnafcillin 4.13 x 10 7 +1.15 R
Bcephalothin 2.46 x 10 5 -.02 S
Btetracycline 1.43 x 10 6 +.01 S
Bchloramphenicol 1.33 x 106 +.01 S
Bclindamycin 3.41 x 107 +.94 R
Berythromycin 2.53 x 10 7 +.69 R
Bgentamcin 1.67 x 10 5 -.02 S
B colistin 1.86 x 10 5 -.02 S
Bkanamycin 2.09 x 10 5 -.02 S
B streptomycin 2.24 x 106 +.04 ' S
Bnitrofurantoin 2.88 x 10 5 -.02 S
54	 1
r^.
Proposed Filtration Procedure for Antibiotic Susce ptibility Testin
Determination of antibiotic susceptibility utilizing a filtration technique has
been adequately tested to date (July 1976) only for seeded prefiltered urines and
broth cultures, i. e. samples requiring no pretreatment that might affect the
viability of bacterial cells in a specimen (Reference 41). Although it has been
shown that the use of TX-Rhozyme-buffer as a pretreatment does not decrease
the level of bacterial ATP in a specimen, it does not necessarily follow that these
bacterial cells would replicate normally under the requisite incubation conditions,
or that a typical antibiogram pattern would be produced. These questions are
presently under investigation.
The filtration susceptibility test is preceeded by any of the detection methods
(centrifugation or filtration) previously outlined. An inoculum representing
approximately 106 organisms is prepared from the specimen, as determined
from the detection data. The specimen is either diluted (in saline) to allow the
application of a 1.0-m1 inoculum, or if necessary, up to 10 ml of specimen may
be filter-concentrated for processing low-level infections. If more than 5 ml
of undiluted specimen are to be processed, it may be necessary to pretreat the
sample with TX-Rhozyme-buffer to prevent clogging of membrane pores. Famil-
iarity with the filtration procedure and various specimen conditions will allow the
technician to determine the advisability of pretreatment.
Development of the filtration procedure for susceptibility tests has involved use of
a Millipore Sampling Manifold. As shown in figures 15 and 16 a minimum of two
plate sets is required for processing, each set being composed of a top sample
port plate and lower filter support plate. To prevent leakage of the sample and
filter movement, the two plates are joined by "C" clamps, creating one unit or
"set"
One plate set is required to process A O I s and determine the initial light response
of the inoculum (without incubation or antibiotic treatment). The A 0 samples mustbe extracted separately, while the A2
.
 5 (normal growth in the absence of anti-
biotics) and B (antibiotic-treated) -samples are incubated on the second plate set(s).
It is recommended that both a standard and blank be processed on each plate set
(that is, with and without incubation) for reagent and sterility control. As any
contamination of the culture medium would result in a false elevation of inoculum
ATP level, it is particularly prudent to obtain the blank light response for use in
calculating the net change in sample light response after incubation. (For further
clarification refer to figures 15 and 16.)
i
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rPLATE SET I
• AO(1
	
INITIAL LIGHT RESPONSE
	
12	 (NO INCUBATION,11	 1	 NO ANTIBIOTICS)
AO(2)
10	 2
	
• 9	 3 BLK
8	 4
STD
7	 6	 5
•	 PLUGGED (UNUSED)
•	 SAMPLE PORT
PLATE SET (SETS) II 	 INCUBATION W/O
	
STD	 ANTIBIOTICSA2.5	 SAMPLE 1
	
BLKO 12	 (1)11	 1
	
4(2)	 61(1)
10	 2
	
B3(2) 9	 3 B2(1)
S	 4
	
B2(2)
	
B3(1)
	 ANTIBIOTICS 1-47
	
6	 5	 SAMPLE 1
B1(2	 A2.5 B40ANTIBIOTICS 1-4
SAMPLE 2	 2)
INCUBATION W/O
ANTIBIOTICS
SAMPLE 2
Figure 15. Antibiotic Susceptibility by Filtration
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HANDWHEEL NUT
SAMPLE PORT PLATE
C	 FILTER SUPPORT PLATE
TEST TUBE RACK
RUBBER GASKET
a
LUCITE PLATE
RESERVOIR BASE
Figure 16. Millipore Sampling Manifold
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Via•
Reagents-
6 percent Triton X-100 (TX)
8 percent Rhozyme-41
1, 5 M TRIS pH 8.3
Saline (0.9 percent)
0.9 percent Saline (with 0.0001 percent TX)
0.1 N HNO3 (in 0.001 percent TX)
0.15 M Na2SO4 (in 0.001 percent TX)
10 mg/ml apyrase in 0.03 M CaC12
Antibiotics (listed previously in this section)
Trypticase Soy Broth (TSB)
(pre-filtration of reagents is recommended)
Procedure-
• Inoculation of Filters, Concentration of Organisms —One inoculum
portion (10 6 organisms) is required for A 0 (plate set I), A2. 5, and each
antibiotic tested (plate set II). A sample requiring pretreatment is
brought to 10 ml (with saline) in a test tube, then treated with 0.2 ml
of TX, 1.0 ml of Rhozyme-41, and 1.0 ml of IRIS buffer. Vortex
and wait 5 minutes for mammalian cell rupture, and degradation of pro-
	 i
tein complexes by Rhozyme.	 ?
The Sampling Manifold is prepared with 8.0 µ cellulose ester membrane':
over a 0.4 N polycarbonate membrane.
Pipette inoculum (1.0 ml diluted specimen or 1-10 ml undiluted specimen
or total volume of pretreated specimen) into sample ports.
Vacuum filter to impinge bacteria on filter membranes.
Wash membranes by filtering 10 ml of saline,
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• Preincubation of All Samples to Reach Log Growth Phase—Remove both
plate sets from manifold chamber and secure on plastic rubber bases
with wing nuts.
Add 0.9 ml of TSB to all sample ports. Incubate all plate sets 30 minutes
O
at 37 C.
• Antibiqttic Testing—Remove plate set(s) II from incubation for introduction
of antibiotics.
Add 0.1 ml of each antibiotic to appropriate B sample ports.
Add 0.1 ml of H2O to each A2 . 5 port.
Swirl plate unit for proper mixing. Return plates to 37 0C incubation for
a 2.5-hour incubation period.
• Determination of A O
 Level—Remove plate set I from incubation after a
30-minute preincubation. Extract A0
 ports (as indicated in the following
step).
Refrigerate collected extract until antibiotic testing is completed and all
extracts can be assayed. (Be sure to allow approximately 10 minutes
for room temperature equilibration prior to assay of refrigerated A0
extracts.)
• Extraction Procedure—Secure plate unit on manifold reservoir base.
Vacuum filter to remove broth.
Add to filter 0. 1 ml 6 percent TX and 1.0 ml of 10 mg/ml Apyrase in
CaC12. Swirl to mix reagents and wait 15 minutes for lysis of mammal-
ian cells and ATP hydrolysis.
Vacuum: filter to remove apyrase solution. Wash by filtering 10 ml
saline-TX to remove any remaining reagent or sample interference.
Filter to dryness.
Remove plate unit, drain off filtrate, and insert collection test tubes
in rack provided. Replace plate unit on manifold base.
Add 0.4 ml of HNO3 to inactivate ATPases and lyse bacterial cells re-
leasing ATP. Wait 5 minutes. Dilute extract by adding 0.4 ml Na2SO4.
Collect extract by vacuum filtration to dryness.
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• Assay of All Extracts (A0 , A2 . 5, B's)—Vortex all tubes.
Assay by injecting 0.1 ml of extract into 0.1 ml of luciferase prepared
in 0.25 M TRIS, pH 8. 2, 1 x 10- 2 M MgSO4 and 1 x 10- 3 M Cleland's
reagent.
• Calculate ATP index according to equation given on page 53.
BACTERIAL LUCIFERASE FLAVIN MONONUCLEOTIDE (FMN) ASSAY
INTRODUCTION
Flavin compounds are ubiquitous in all organisms. The detection of such com-
pounds can give quantitative information on the number of bacteria present due
to pathological disorders in body fluids such as urine or blood. In addition, by
using selective methods, abnormalities of flavin concentrations due to metabolic
disorders may also be evaluated (Reference 8). The bioluminescent reaction for
the detection of flavins is more sensitive than fluorometric techniques and does
not suffer from interferences which would affect other techniques. The sensitivity
of methods for FMN assay are listed as follows:
Sensitivity of Methods for FMN Assay (Reference 8)
Method	 Lower limit of detection
(micrograms)
Paper chromatography	 0.01
Cytochrome c reductase
	 0.01
Lactic oxidase	 1
F luorometry	 0.0001
Bacterial bioluminescence	 0.00001
The proposed applications of the bacterial luciferase FMN assay include enu-
meration of bacteria in sewage effluent, water, blood, urine, ambient air,
(Reference 42), industrial wastes, and clean-room air studies. The assay has
been used in the determination of riboflavin, FMN, FAD (flavin adenine di-
nucleotide) flavin enzymes, flavin vitamins, flavoproteins, and a variety of in-
organic and organic chemicals in air samples,-
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aLuminous bacteria have been used to study the mechanism of the action of drugs
(Reference 43). Johnson et al., (References 44 and 45) using dimming time as
a measure of respiration of luminous bacteria, were able to measure the effects
of various narcotic agents on the luciferase enzyme.
An in vitro system using Photobacterium phosphoreum has been developed which
can determine the concentration of an aqueous solution of gentamicin in concen-
trations as low as 1.25 pg/ml. This is done by measuring the light intensity of
a control culture and the subsequent decrease in light intensity of the bacterial
"	 culture when exposed to gentamicin. This test system is being developed for
measuring antibiotic levels in blood serum (Reference 46).
LUMINESCENT BACTERIA
Luminescent bacteria have been found in fresh water, sea water, in insects,
fresh and salt water shrimp, amphipods, and other marine organisms. They
have also been found living saprophytically on dead fish or meat and in mutu-
alistic associations in the luminous organs of fish or squid. Incubation of dead
fish or squid at 15 0to 200C overnight will reveal small luminous colonies devel-
oping on the animals , surfaces. When some of the glowing material is transferred
to an agar plate, the colonies that develop may reveal motile or sessile luminous
bacteria of long or short rods, cocci or vibrios. The characteristic of light
emission is not a constant feature and the ability to emit light may be lost during
maintenance on artificial laboratory culture media.
Some of these bacteria, which can be obtained from the American Type Culture
Collection, 12301 Parklawn Drive, Rockville, Md. 20852, are discussed in the
Appendix.
CULTURE MEDIA	 1
Various complex media have been used to isolate and culture these micro-
organisms. The media generally contain sea water or artificial sea water.
Some strains have been grown on synthetic media, also.
The complex media may contain a natural carbon and energy source such as
fish muscle extract, peptone or tryptone. Glycerol has also been used as a
carbon and energy source. In one species, P. phosphoreum, methionine ap-
peared to bean essential growth factor (Reference 47),
A commercially available medium is Photobacterium Broth (Difco) which is
suitable for many marine luminescent bacteria.
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Another medium is artificial sea water consisting of 0.4 M NaCl, 0.1 M MgSO4
7 H2O, 0.02 M KCl, and 0.02 M CaCl2 • 2 H2O (Reference 48). Basal medium
broth (BM) contains 50 mM TRIS HCl (pH 7. 5), 19 mM NH 4C1, 0.33 mM K2HPO4.
3 H20), 0.01 mM FeSO4
 and half-strength artifical sea water (Reference 48).
Basal medium agar (BMA) is prepared by sterilizing separately and then mixing
equal volumes of double-strength BM and 20 g of Difco Noble Agar per liter.
Compounds serving as sole sources of carbon and energy are filter-sterilized
(0.2µ Nucleopore) and added to the already autoclaved medium. For a complex
broth or agar add 5 g Bacto-Peptone, 3 g Difco Yeast Extract, and 3 ml glycerol
to the recipe from BM.
BACTERIAL LUCIFERASE
Luminescent bacterial luciferases are self-induced enzymes, induced by an
active compound (autoinducer) which accumulates in the culture medium. When
the concentration of autoinducer attains a critical level, synthesis of luciferase
occurs (Reference 49). The autoinduction mechanism has been described by
Eberhard (Reference 49), Nealson, and (Reference 50 and 51). Autoinducer
can be extracted from the culture medium by 2 successive two-volume extract-
ions with ethyl acetate. When a strain of V. fischeri (ATCC 7744) was grown
in a culture medium, the growth of the cells was continuous from the time of
inoculation, while luminescence lagged for nearly 3 hours (Reference 51). The
explanation for this delay consists of two factors. The first is an inhibitor
which is present in complete medium and must be removed (References 47 and 49).
Various marine bacteria can remove this inhibitor* leaving what Nealson refers
to as a conditioned medium. The second factor is the time needed for production
of autoinducer which stimulates synthesis of the luminous system.
pH Range of Bacterial Luciferase
At ordinary temperatures, activity of the bacterial luciferase appears to be
stable in the acid range down to pH 4.0. Tests performed in our laboratory
indicate that the luciferase system from V. fischeri, strain A-13 t is active
from a pH of 5.8 to 7.2 with optimal luminescence between 6.8 and 7.0. Stability
of the system from V. fischeri, strain MJ-1tt is between pH 6.0 and 7. 3 with
*Nealson, Scripps Institute of Oceanography, LaJolla, California 92093, un-
published data.
tObtained from Dr. John Lee, Dept, of Biochemistry, University of Georgia,
Athens, Georgia 30601,
itObtained from K. H. Nealson, Scripps Institute of Oceanograph, LaJolla
California 92093.
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an optimum between pH 6.3 and 6.8. The differences between the enzymes may
be slight as far as pH optima are concerned. However, in transferring cultures
for maintenance of the MJ-1 strain of V. fischeri, light intensity is more con-
sistently reproduced than in the A-13 strain, where appearance of dark mutants
is common. i
i
Preparation and Partial Purification of Luciferase
Culture and Harbest of Vibrio fischeri (Reference 52) Incubate organisms in
a shaking flask of Photobacterium Broth (Difco) at 25°C for a minimum of 5 hours.
When brightly glowing, spread culture on a large shallow tray containing Photo-
bacterium broth and 0.8 percent agar at a depth of 1/4 to 3/8 inches. Cover
trays to prevent agar from drying out and incubate at 25°C overnight. Harvest
the luminescent colonies by scraping the surface of the agar with a rubber
spatula.
Extraction of Proteins--Add 500 ml of cold acetone to the cells and blend for one
minute at 10°C in a Waring blender. Collect .extracted proteins on a Whatman
#41 filter using a Buchner funnel and air dry (Reference 53).
Removal of Proteins Other than Luciferase—Add 150 ml of 0.05 M IRIS, 10-3
M Cleland's pH 7. 1, to 3 grams of the acetone powder. Shake this suspension
for 15 minutes to allow for extraction of the soluble protein fraction containing
luciferase. Centrifuge at 8000 RCF x G for 20 minutes at 5 0C, collect the
supernate (130 ml) and discard the pellet.
Add 22.88 grams of (NH4) 2SO4 to the supernate (30 percent saturation) and
shake for 15 minutes at room temperature to precipitate proteins other than
luciferase. 'Centrifuge at 30, 000 RCF x G for 20 minutes at 20 0C, collect the
supernate (140 ml), and discard the pellet.
Precipitation of Luciferase—To the supernate add 22.88 grams of (NH4)2SO4
(70 percent saturation) and shake the suspension for 15 minutes at room tem-
perature. This concentration of ammonium sulfate allows for precipitation of
the luciferase enzyme. Centrifuge at 30, 000 RCF x G for 20 minutes at 20 0C,
discard the supernate, and wash the residue once in 100 ml of 70 percent
(NH4) 2504 , pH 7. 1 at room temperature. Let stand for 10 minutes.
Elution of the Enzyme—Apply the precipitate to the top of a Sephadex G 200
column and elute off the column in 0.05 M IRIS, 10- 3 M Cleland's reagent,
pH 7.1. Collect samples in a fraction collector.
4
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rAssay for Active Fractions of Luciferase (Reference 52)—To 1.0 ml standard
FMN solution (100µg/ml) in a polypropylene test tube, add 1.0 ml PdC1 2 solution
(0.17 mg/ml in 0.1 M TRIS, pH 7.0) and 1.0 ml NaBH4 (14.8 mg/ml in same
TRIS). Wait 10 minutes for reduction of FMN to FMNH2.
Inject 0.1 ml of sample into a cuvette containing 0.2 ml enzyme fraction plus 0.1
ml dodecyl aldehyde. Pool the most active fractions, those producing the most
light when reacted with the reduced FMN standard, for subsequent use in cellular
and/or soluble FMN assays.
Known Sources of Prepared Bacterial Luciferase
Sigma Chemical Company
P. O. Box 14508
Saint Louis, Missouri 63178
Luciferase Type I, Bacterial; Purified from V. fischeri ATCC No. 7744
(prepared for Sigma)
Luciferase Type II, Bacterial; Purified from V. fischeri ATCC No. 7744
ICN Pharmaceuticals, Inc.
26201 Miles Road
Cleveland, Ohio 44128
Luciferase, Partially purified powder from V. fischeri
Worthington Biochemical Corporation
f	 Freehold, N. J. 07728
Luciferase, Partially purified dried powder from V. fischeri
DETERMINATION OF FMT%! iN FLUIDS d
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-3Reagents	 I
Extractants—Original work with the FMN assay involved the use of perchloric
acid as an extractant (Reference 53). However, a 0.2 N extraction concen-
tration of nitric acid (HNO 3), or a solution of 0.1 M boiling TRIS, may also be
used as an effective extractant of FMN and FAD. The following procedures
incorporate the use of nitric acid as the extractant,
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Lumiflavin, a photolysis product of riboflavin, may be added to the acid extract-
ing solution to retard photodegradation of FMN and FAD without inhibiting the
luciferase reaction. Immediately before use, dissolve 10 mg lumiflavin in 250
ml of distilled H2O and add 1.0 ml of this solution of 100 ml of the acid extract-
ing solution.
Palladium Chloride (PdC12)—A 0.002 M solution of PdC12 in 0.1 M TRIS buffer
at pH 7.0 or in 0.4 N potassium hydroxide (KOH) serves as a catalyst for the
reduction of FMN to FMNH2. KOH neutralizes the acid extractant. Purified
palladium chloride is available from Fisher Scientific Company.
TRIS (Hydroxymethyl Amino Methane)—A 0.1 M solution of TRIS at pH 7.0 is
used as a buffer.
Sodium Borohydride (NaBH4)—Sodium borohydride reduces FMN. Prepare a
0.4 M solution in 0.4 N KOH immediately before use. A 98 percent pure powder
is available from Fisher Scientific Company.
Dodecyl aldehyde—Dodecyl aldehyde is a necessary cofactor for the bacterial
luminescent reaction. To prepare immediately before assay, suspend 0.1 ml
of concentrated aldehyde in 5.0 ml of luciferase solution and disperse with
shaking. The aldehyde can also be added before lyophilizing the preparation of
luciferase to give the same final concentration when the enzyme is hydrated
with distilled water or buffer.
9
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Luciferase—The bacterial luciferase solution used in the FMN assay is the
result of pooling active fractions from Sephadex G-100 columns in 0.05 M IRIS,
pH 7, 0. The subsequently lyophilized enzyme is rehydrated by adding 4.5 ml	 1
of 0.4 M TRIS buffer, pH 7.. 0. (Refer to section on preparation and partial
purification of bacterial luciferase.)
Flavin Mononucleotide (FMN)-Serial dilutions of FMN in distilled ` water are
used for preparation of standard, curves from which unknown concentrations of
FMN can be determine
Procedure for Measuring Soluble FMN (Reference 8)
Reduction of F.MN—To a 1.0 ml sample add 1.0 ml PdC12 solution 0.7 mg/ml
In 0.1 TRIS, pH 7.0) to serve as a catalyst for FMN reduction. Add 1.0 ml
NaBH4 solution (14.8 mg/ml in same TRIS, prepared immediately before use)
and allow for an FMN reduction time of 10 minutes. Sample must be assayed
within 20 minutes after reduction by borohydride.
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Assay for FMN—Assay by injecting 0.1 ml sample into 0.3 ml luciferase solution
(0.2 ml luciferase, 0.1 ml dodecyl aldehyde) in a 6 x 50-mm test tube mounted
in front of a photomultiplier tube. Record light units.
Procedure for Measurin g Cellular FMN
Extraction of Flavins from Cellular Material —Toone ml of an aqueous cellular
suspension add 1.0 ml of PdC12 solution made up in nitiric acid (0.17 mg/ml in
0.4 N HNO3). Allow acid to react for 5 minutes to rupture cells and free FMN
and FAD from protein.
Reduction of FMN-Add 1.0 ml of the NaBH4 solution (14.8 mg/ml in 0.4 N KOH,
prepared immediately before use) to reduce FMN in the sample. Add 1.0 ml
0.4 M IRIS, pH 6. 4, to stabilize pH for optimal enzyme activity. Allow for a
reaction time of 10 minutes (not more than 20 minutes).
Assay for FMN—Assay by injecting 0.1 ml of sample into 0.3 ml of the lucif-
erase solution (0.2 ml luciferase, 0.1 ml dodecyl aldehyde) in a 6 x 50-mm
test tube mounted in front of a photomultiplier tube. Record light units.
Practical Considerations
The extraction of flavins from cellular material and subsequent assay steps
should be carried out with minimal exposure to light. In order to minimize
surface adsorption and degradation of the flavins, use polypropylene containE rs,
pipettes, and syringes as much as possible.
The addition of TRIS buffer to the sodium borohydride cuases the evolution of
hydrogen gas bubbles. The solution should be pipetted with a safety pipetter
or a rubber bulb attached to the pipette. When adding to the cells in a calibrated
test tube, the borohydride solution is added until the liquid reaches the 3 ml
j	 mark. The addition of borohydride causes the FMN solution to darken and many
small bubbles to appear. While still darn and bubbly, the solution should be
assayed.
The temperature of the extractant used is critical for determining FMN content
versus the total phosphoflavin (FMN plus FAD) content of a sample. Acid ex-
tractants at cold temperatures (near 40C) allow for specific measurement of
FMN only; complete conversion of extracted FAD to FMN for a total phospho-
flavin measurement can be ensured by boiling the sample before adding PdC12.
The difference between the total phosphoflavin and FMN values represents the
concentration of FAD in the sample.
<9
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When extracting and measuring FMN from pure bacterial cultures, t
of extracellular FMN that might falsely elevate the bacterial FMN va
as to be insignificant. To detect bacteria in fluid samples containing
stantial levels of background flavins, the cells can be concentrated a
to remove extracellular flavins and to increase sensitivity. At pres(
method exists for simple hydrolysis of interfering flavins before ext
bacterial FMN, although a selective enzymatic hydrolysis system is
vestigation at Goddard Space Flight Center (Reference 54).
Calculations
The FMN content of a sample is calculated by reference to a standar,
prepared from measurements of light intensity obtained with known c
of FMN subjected to the 'same conditions as the unknown sample. Th
trations prepared should be such that the injected 0.1-m1 volumes contain
quantities of FMN ranging from 10- 1
 µg to 10-4
 µg, Values from blank assays
using water in place of the FMN solution should be subtracted both from the
standard curve and from the unknown values. Since the reaction is linear, a
single point of standard FMN may be used for calculating the unknown values.
Examples of Values
One ml of 0.1 M boiling TRIS buffer at pH 6. 7 extracts 7 x 10- 4
 µg FMN per
ml of Pseudomonas aeruginosa, corresponding to approximately 1 x 10- 10
 ug
FMN per cell. Following is a list of the total amount of FMN and FAD extracted
by boiling in perchloric acid from various bacteria grown to early maximum
stationary phase*.
Organism	 pg FLAVIN/Cell ( x10-10)
Bacillus globigii
	 61.0
Brevibacterium helvolum
	 9.0
Escherichia_coli	 1.9
Flavobacterium arboresceus
	 65.4
Kelbsiella pneumoniae
	 1.8
*Picciolo, Chappelle, Goddard Space Flight Center, Greenbelt, Md. , (unpublished
data).
i
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JOrganism	 µg FLAVIN/Cell ( x 10-10)
Micrococcus lysodeikticus 	 21.0
Pseudomonas aeruginosa
	 1.8
Pseudomonas fluorescens 	 2.6
Proteus vulgaris	 1.4
Serratia marcescens	 1.6
Spirillum Serpens	 0.2
Staphylococcus aureus 	 0.7
The flavin content of several biological fluids has been determiner) using a 6 per-
cent butanol solution in 0.01 M TRIS buffer as an extractant (Reference 8);
Fluid	 Ag FMN/ml
Urine	 I x 10-11
Whole blood (5.5 x 106 rbc/mm3)	 5.0
Serum	 1.1
9
Sensitivity
Under the conditions cited in the description of procedure, approximately 105
bacteria per ml are required for reliable results. A sample containing fewer
bacteria will have to undergo concentration by centrifugation or filtration.
Conditions for Use
The FMN bacterial detection system remains to be applied to clinical specimens.
Predictable advantages over the firefly luciferase ATP assay would include low
cost of enzyme and the measurement of a metabolically less variable cellular
constituent. The determination of an ATP/FMN relationship may prove to be
a useful description of the health or energy potential of cells in a sample. y
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LUMINOL CHEMILUMINESCENT SYSTEM
INTRODUCTION
The luminol chemiluminescence method for detecting bacteria in fluid samples
may provide an alternative to the more expensive assays already described.
Like the other luminescent reactions, the luminol chemiluminescence method
is a sensitive, simple, and rapid method for bacterial detection. Unlike the
luciferase enzymes, however, luminol is readily available in large quantities
at low cost and remains stable indefinitely. Although previously applied to
the analysis and detection of iron H (Reference 55), hydrogen peroxide as a
result of glucose oxidation (Reference 56), ferricyanide (Reference 57), and
hematin compounds (Reference 58), the luminol chemilumine scent reaction has
been modified for detecting bacteria in fluid samples by incorporating inter-
ference removal techniques. (References 59 through 63.)
Luminol (5-amino -2, 3-dihydro -1, 4-phthalazinedione) chemiluminescence
is produced by the reaction of an aqueous alkaline luminol solution with hydrogen
peroxide and an activating agent consisting of an oxidizing agent such as ferri-
cyanide, hypochlorite or a chelated transition metal such as iron or copper.
In bacterial detection systems, it is assumed that iron porphyrins (peroxidase,
cytochrome, catalase), contained in microbial cells serve as the activators for
luminol chemiluminescence.
REAGENTS
Luminol Stock
Combine 0.8860 g of luminol (Sigma Chemical Co., St. Louis, Mo.) * and 60 g
sodium hydroxide per liter deionized water to obtain a stock luminol solution
that remains stable for several months.
Hydrogen Peroxide (119,09,)
A 3 percent solution of hydrogen peroxide is added to the sample as a pretreat-
ment for elimination of extra-bacterial porphyrins and is also required for the
luminol reaction.
*Also available from J. T. Baker Chemical Co., 222 Red School Lane, Phillips-
burg N, J. 08865; Eastman Kodak Co., Eastman Organic Chemicals, 343 State
St., Rochester, N.Y. 14650; and other chemical companies.
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Sodium Hydroxide (NaOH)
A final concentration of 0.75 N sodium hydroxide extracts porphyrins from
bacteria and provides the pH necessary for the luminol reaction.
Luminol Reagent
Combine 10 ml of luminol stock, 6. 6 ml of 3 percent hydrogen peroxide, 90
ml of 1.5 N sodium hydroxide, and 93.4 ml of deionized water to achieve a
200-m1 solution of 2.5 x 10-4 M luminol, 0. 1 percent hydrogen peroxide, and
0.75 N sodium hydroxide that remains stable for at least 24 hours.
APPARATUS
The luminol reaction can be performed as an injection system using the instru-
ments described previously. However, a flow system has been developed
that lends itself to automation. This luminol flow system requires a light-tight
chamber containing a coiled glass flow cell (available from the American Instru-
ment Company for use with the Chem-Glow), and a four-channeled Buchler
peristaltic pump,
PROCEDURE (PLOW SYSTEM
Sample Pretreatment
The sample is introduced into the flow system (see figure 17) by the action of
the peristaltic pumps and mixes with 3 percent hydrogen peroxide for a period
of 2 minutes. Hydrogen peroxide pretreatment causes rapid degradation of free
porphyrins and as a result removes 90 percent of any soluble extracellular iron
porphyrins which may be contaminating the sample. 	
1
Luminol Reaction
i
The next step allows the sample to react with the luminol reagent for a period
of 10 seconds before reaching the flow cell and photomultiplier. This step,
reaction rate resolution, eliminates the short-lived luminol responses due to
inorganic interferences (see figure 18). Since the peroxide pretreatment elim-
inates soluble porphyrins, the peak light response after 10 seconds reflects
only the bacterial porphyrin concentration.
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ALTERNATIVE PROCEDURE (INJECTION SYSTEM)
Sample Pretreatment
To a 7. 5-ml sample in a test tube add 1.0 ml of 3-percent hydrogen peroxide
and let stand 2 minutes for degradation of soluble porphyrins.	 1
Luminol Reaction
d
Inject 0.15 ml of the peroxide-treated sample into a cuvette containing 0. 1.5 ml
of luminol reagent. Record light units after ten seconds to preclude measure-
ment of short-lived light responses from inorganic interferences.
CALCULATIONS
Luminol light units are converted to bacteria per ml by referring to a standard
bacterial concentration curve obtained by measuring luminol responses of serial
dilutions of washed bacterial cells, E. coli for example. Concentrations are
determined by standard plate-count methods. With the luminol flow system one
light unit has been shown to be equivalent to about 1.5 x 10 6 bacteria per ml
sample,
SENSITIVITY
The luminol flow or injection system can be used to detect bacterial levels as
low as 1 x 104 E. coli per ml. If concentrations of bacteria are expected to
be less than 10 f`-per ml, a method of concentration is necessary. Filter an
appropriate volume of sample through a 0.45N, 22-mm or 47-mm Gelman
acropore filter and holder. Add 5.0 ml of 0.5 percent hydrogen peroxide to the
filter and wait 2 minutes before vacuum-washing with about 10 ml of deionized
water. Extract bacterial porphyrins with 0.1 N sodium hydroxide - 50 percent
ethanol for 30 seconds and collect by vacuum. Assay with the luminol reaction
system without using the 3 percent hydrogen peroxide step,
MEDICAL APPLICATIONS
Another huminol procedure has been used by Ewetz to detect bacteriuria, "corn-
bining a high rate of positively identified bacteriurias (>99 per cent) due to its
high sensitivity, with an acceptably low rate (7 per cent) of false positives in an
unselected clinical material" (Reference 61). Since hemoglobin is a luminol
activator, a problem does exist when blood is present in the sample, however
this method may still be a valuable tool in screening large numbers of urine
samples for bacterial infections.
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The determination of iron porphyrins by luminol in clinical samples, either as
an assay for bacterial levels or perhaps as a measure of blood or hemoglobin,
may prove useful as long as interference from other materials that activate
the response is removed. A ratio of values (luminol/ATP/FMN) may be shown
in the future to characterize various body fluids.
SUMMARY
The characterization of a clinical sample by a simple, fast, accurate, automa-
table analytical measurement is important in the management of infectious
disease. Luminescence assays offer methods rich with options for these measure-
ments. The instrumentation is common to each assay, and the investment is
reasonable.
Three general procedures have been developed to varying degrees of complete-
ness which measure bacterial levels by measuring their ATP, FMN and iron
porphyrins. Bacteriuria detection and antibiograms can be determined within
half a day. The characterization of the sample for its soluble ATP, FMN or
prophyrins can also be performed.
The utility of these assays for clinical samples as well as their versatility will
be further demonstrated as their clinical use expands (Reference 65).
ja
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LUMINESCENT BACTERIA
1. Vibrio fischeri (Photobacterium fischeri, Achromobacter fischeri)
(Reference 64). (nomenclature from Bergey's Manual of Determinative Bacte-
riology 8th Ed)
Vibrio fischeri are found in sea water and marine animals. The cell, a motile
rod, (mainly lophotrichous although some strains are monotrichous) is gram-
negative and usually requires 2.8 percent NaCl for growth. It grows at 5"C
but not at 37 C. The temperature for optimum luminescence is 25°C. The
organism can be grown only aerobically.
3
2. Photobacterium phosphoreum
The cells are coccobacillary or rods, usually motile with polar flagella, and
are gram-negative. Some strains do not grow well on nutrient media, unless
the NaCl concentration is 2.0 to 3.0 percent.
They are chemorganotrophs with a carbohydrate metabolism that is fermentative.
The organism can grow at 5°C but not at 37 0C. The optimum temperature for
luminescence is approximately 15°C.
3. Genus Beneckea.
The genus Beneckea, as described by Baumann et al. , 1971, (Reference 66) is
regarded as a genus of uncertain taxonomic position by the authors of Bergey's
Manual, 8th Ed. (Reference 64).
Baumann describes these organisms as straight or slightly curved rods, gram
negative, facultatively anaerobic marine organisms. Some of the strains have
single polar flagella when grown in either liquid or solid culture media; other
have single polar_ flagella in liquid culture, but when transferred to solid culture
media, they develop peritichous flagella. They decompose chitin and ferment
	 !,
glucose with the production of acid but no gas. Some strains grow at 4°C; some
at 35 00, and some at as high as 400C. Their luminescence has been studied by
Hastings (Reference 67).
d
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